University of Mississippi

eGrove
Industry Guides (AAGs), Risk Alerts, and
Checklists

American Institute of Certified Public
Accountants (AICPA) Historical Collection

1-1-1993

Checklists and illustrative financial statements for health care
providers : a financial accounting and reporting practice aid, May
1993 edition
American Institute of Certified Public Accountants. Technical Information Division
Martin S. Safran

Follow this and additional works at: https://egrove.olemiss.edu/aicpa_indev
Part of the Accounting Commons, and the Taxation Commons

Recommended Citation
American Institute of Certified Public Accountants. Technical Information Division and Safran, Martin S.,
"Checklists and illustrative financial statements for health care providers : a financial accounting and
reporting practice aid, May 1993 edition" (1993). Industry Guides (AAGs), Risk Alerts, and Checklists. 847.
https://egrove.olemiss.edu/aicpa_indev/847

This Book is brought to you for free and open access by the American Institute of Certified Public Accountants
(AICPA) Historical Collection at eGrove. It has been accepted for inclusion in Industry Guides (AAGs), Risk Alerts,
and Checklists by an authorized administrator of eGrove. For more information, please contact
egrove@olemiss.edu.

May 1993 Edition

Checklists and Illustrative

Healthfor
vide
Care
rsPro
A FINANCIALP
REPORTING
Financial Statements

American Institute of Certified Public Accountants

CHECKLISTS AND ILLUSTRATIVE FINANCIAL STATEMENTS IN THE SERIES

Checklists and Illustrative Financial Statements for Corporations

Checklist Supplements and Illustrative Financial Statements
Checklist Supplement and Illustrative Financial Statements for Construction Contractors
Checklist Supplement and Illustrative Financial Statements for Investment Companies
Checklist Supplement and Illustrative Financial Statements for Oil and Gas Producing Companies
Checklist Supplement and Illustrative Financial Statements for Real Estate Ventures
Checklist of Emerging Issues Task Force Consensuses

Industry Checklists and Illustrative Financial Statements
Checklists and Illustrative Financial Statements for Agricultural Cooperatives
Checklists and Illustrative Financial Statements for Banks
Checklists and Illustrative Financial Statements for Colleges and Universities
Checklists and Illustrative Financial Statements for Common Interest Realty Associations
Checklists and Illustrative Financial Statements for Credit Unions
Checklists and Illustrative Financial Statements for Defined Benefit Pension Plans
Checklists and Illustrative Financial Statements for Employee Health and Welfare Benefit Plans
Checklists and Illustrative Financial Statements for Finance Companies
Checklists and Illustrative Financial Statements for Health Care Providers
Checklists and Illustrative Financial Statements for Fife Insurance Companies
Checklists and Illustrative Financial Statements for Not-for-Profit Organizations
Checklist and Illustrative Financial Statements for Personal Financial Statement Engagements
Checklists and Illustrative Financial Statements for Property and Eiability Insurance Companies
Checklists and Illustrative Financial Statements for Prospective Financial Statement Engagements
Checklists and Illustrative Financial Statements for Savings Institutions
Checklists and Illustrative Financial Statements for State and Focal Governmental Units

May 1993 Edition

Checklists and Illustrative
Financial Statements for Health Care Providers A FINANCIAL ACCOUNTING AND REPORTING PRACTICE AID

Edited by
Martin S. Safran, CPA
Technical Manager
Technical Information Division

Checklists and Illustrative Financial Statements for Health Care Providers has
not been approved, disapproved, or otherwise acted upon by any sen
ior technical committees of the American Institute of Certified Public
Accountants or the Financial Accounting Standards Board and has no
official or authoritative status.

American Institute of Certified Public Accountants

Copyright © 1993 by
American Institute of Certified Public Accountants, Inc.,
New York, NY 10036-8775

All rights reserved. Requests for permission to make copies of any part of this
work for redistribution or for inclusion in another document or manuscript
should be mailed to Permissions Department, AICPA, Harborside Financial Center,
201 Plaza Three, Jersey City, NJ 07311-3881.
1234567890 TI 99876543

CHECKLISTS AMD ILLUSTRATIVE FINANCIAL STATEMENTS
FOR HEALTH CARE PROVIDERS

The checklists and illustrative financial statements in this
publication have been
developed by the staff of the Technical
Information Division of the AICPA as nonauthoritative practice aids.
Readers should be aware of the following:

•

The checklists and illustrative financial statements and
reports are "tools" and do not represent official positions or
pronouncements of the AICPA.

•

The checklists and illustrative financial statements and
reports have been updated through FASB Statement No. 109,
FASB Interpretation No. 39, FASB Technical Bulletin No. 90-1,
AICPA Statement of Position No. 92-3, AICPA Statement on
Auditing Standards No. 71, AICPA Statement on Standards for
Accounting and Review Services No. 7, and AICPA Audit and
Accounting Guide, Audits of Providers of Health Care Services
(Second Edition 1991).
The checklists and illustrative
financial statements and reports should be modified, as
appropriate, for subsequent pronouncements.
In determining
the applicability of a pronouncement, its effective date
should be considered.

•

The checklists and illustrative financial statements should be
used by, or under the supervision of, persons having adequate
technical training and proficiency in the application of
generally accepted accounting principles, generally accepted
auditing standards, and statements on standards for accounting
and review services.

•

The checklists and illustrative financial statements and
reports do not represent minimum requirements and do not
purport to be all-inclusive. The referenced standards should
be reviewed if clarification is desired as to whether the
disclosure indicated is required or suggested, and to what
extent the disclosure is relevant to the statements and report
being issued.

Users of the checklists and illustrative financial statements and
reports are urged to refer directly to the applicable authoritative
pronouncements when possible.
If you have a question, please call the
AICPA Technical Hotline (see back cover).
The author wishes to acknowledge the assistance of his colleagues,
Annette J. Schumacher, CPA, Michael A. Tursi, CPA, and David J. Perlman,
CPA, who served as consultants on this project, and to the members of
the AICPA Health Care Committee for their comments and suggestions.
Susan L. Menelaides
Director
Technical Information
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INTRODUCTION
Health care costs as well as the number of people requiring health care
services has consistently risen.
As a result, many health care
providers are relying more heavily on debt financing to meet capital
needs creating a greater need for accountability to creditors and
investors.
Health care entities may be classified by sponsorship or legal structure
within
three
broad
categories:
voluntary
(not-for-profit),
governmental, and investor- (or operator-) owned.

Voluntary (Not-For-Profit):
an entity that operates under the
direction of governing boards.
Usually exempt from federal and
state
income taxes
if operated exclusively for religious,
charitable, scientific or educational purposes, the entity may be
further classified as community-based, religious-affiliated or
university-sponsored.
Governmental: Often called public health care entities, the entity
is owned and operated by federal, state, city or county governments
or other political subdivisions.
Investor- (or operator-) Owned: a health care entity that operates
as a stock corporation, partnership or sole proprietorship.

Health care entities include, but are not limited to:

o

Clinics, medical group practices, individual practitioners and
practice associations, and other ambulatory care organizations

o

Continuing care retirement communities (CCRCs)

o

Health maintenance organizations and similar prepaid health
care plans

o

Home health agencies

o

Hospitals

o

Nursing homes that provide skilled,
intensive levels of health care

o

intermediate,

and less

Parent, holding and other organizations that primarily plan,
organize and oversee health care services

Legislation and Regulation
Significant aspects of
government legislation
governing the granting
rendered. In addition,

health care entity operations are affected by
and regulation with many states adopting laws
of licenses as well as scope of services to be
many independent organizations and governmental
1

agencies,
including Medicare and Medicaid, evaluate programs
services of health care entities to determine compliance with
standards.

and
set

Basic Financial Statements
The basic financial statements of not-for-profit and governmental health
care entities generally consist of a balance sheet, statement of
revenues and expenses of general funds, statement of changes in fund
balances, and a statement of cash flows of general funds (and restricted
funds of governmental entities).
The basic financial statements of
investor-owned health care entities are similar to those of other
investor-owned entities.
Aggregated (combined fund) and disaggregated
(layered fund) balance sheets are acceptable alternatives to reporting
financial
position
of
not-for-profit
health
care
entities
and
governmental hospitals.

Structure of the Checklist

In July 1990, the AICPA published a new audit and accounting guide
entitled Audits of Providers of Health Care Services (the Guide) .
The
recommendations contained in the Guide and this checklist apply to the
separate financial statements of health care entities that are either
(a) investor-owned, (b) not-for-profit or (c) state or local governmentowned users of enterprise fund accounting and reporting.
Financial
statements of a state or local governmental health care entity are
subject to statements and interpretations of the Governmental Accounting
Standards Board (GASB) as well as AICPA and Financial Accounting
Standards Board (FASB) pronouncements as specified by GASB statements
and interpretations. This checklist presents fund accounting guidance
first.
Any modifications needed to reflect non-fund accounting are
presented in brackets immediately after the related fund accounting
guidance.

Not-for-profit health care providers that receive federal financial
assistance may be required to have an audit conducted in accordance with
Office of Management and Budget (OMB) Circular A-133, Audits of
Institutions of Higher Education and Other Nonprofit Institutions.
Appendix A is a supplemental checklist for auditor's reports for audits
performed under A-133.
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Checklists--General

Many Auditors and accountants find it helpful to use checklists as
practice aids in preparing financial statements and reports. Some
firms have developed their own checklists for internal use, and may
also have specialized checklists to meet the needs of their
practices, such as checklists for clients in particular industries
or clients that report to the SEC.
Some state CPA societies have
developed checklists as practice aids that may be available to
other practitioners as well as to their own members.
Some
commercial publishers also include checklists in certain of their
publications.
However, authoritative literature does not require
the use of such checklists, nor does it prescribe their format or
content, which may vary.

Checklists typically consist of a number of brief questions or
statements that are accompanied by references to Statements on
Auditing Standards, Statements on Standards for Accounting and
Review Services, Statements of Financial Accounting Standards,
Accounting Principles Board Opinions and Accounting Research
Bulletins.
Some checklists also include references to FASB
Interpretations, Statements of Position and Industry Audit Guides.
The extent of detail included in checklists varies with the
judgment of the preparers on how extensively to refer to and
highlight authoritative literature without developing a checklist
that is too long and unwieldy. Accordingly, checklists may serve
as convenient memory aids but cannot be used as a substitute for
direct references to the authoritative literature.
Checklists usually provide for checking off or initialling each
question or point to show that it has been considered. The format
used herein is a typical one; it provides for "yes," "no," and "not
applicable" answers and presumes that remarks would be prepared on
separate cross-referenced memorandums.
Some preparers, however,
prefer to include space for remarks in the body of the checklist
while others prefer alternative checklist formats. For example, a
checklist format may provide for the following set of answers: "not
applicable," "not material, " "in statements," and "in notes" (with
provisions for indicating a cross reference to the specific
statement caption or note).
Another format may provide for only
two answers,
"disclosed" and "not applicable."
Firms and
practitioners who develop their own checklists should adopt formats
that suit their needs and preferences.
Disclosure checklists are generally accompanied by caveats that
include all of the following points:

•

Use of the checklists requires the exercise of individual
professional judgment and may likely require some
modification based on the circumstances of individual
engagements.

•

The checklists are not all-inclusive and are not intended

3

to present minimum requirements.

•

Users
need
to
modify
the
checklists
for
any
pronouncements issued subsequent to those mentioned in
the checklist.

If widespread circulation is expected, the preparers also generally
stress the nonauthoritative or unofficial status of the checklists
and disclaim responsibility for the way they may be used.

4

Explanation of References

AAG or Guide

=

AICPA Audit and Accounting Guide. Audits of
Providers of Health Care Services. Second
Edition

AC

Section in FASB Accounting Standards Current
Text

APB

AICPA Accounting Principles Board Opinion

AR

AICPA Professional Standards

ARB

AICPA Accounting Research Bulletin

AU

AICPA Professional Standards

FASBI

FASB Interpretation

FASCON

FASB
Statement
Concepts

SAS

AICPA Statement on Auditing Standards

SFAS

FASB
Statement
Standards

SOP

AICPA Statement of Position

SSARS

AICPA Statement on Standards
and Review Services

TB

FASB Technical Bulletin

5

of

of

(vol. 2)

(vol. 1)

Financial

Financial

Accounting

Accounting

for Accounting

CHECKLIST QUESTIONNAIRE
This checklist has been developed by the staff of the Technical
Information Division of the AICPA as a nonauthoritative practice
aid.
Yes
I.

No

ACCOUNTING PRINCIPLES OF MEASUREMENT AND
DISCLOSURE

A. Fund Accounting
1.

General funds

a.

b.

For classified balance sheets, are assets
and liabilities classified as current and
noncurrent, with totals presented for
current assets and current liabilities?
[AAG, par. 3.04; ARB 43, Ch. 3A
(AC B05.103-.109); SFAS 6, par. 15
(AC B05.118); TB 79-3 (AC B05.501-.503)]

_________

Are the following limited-use assets
included in the general funds?

.
(1)

Board-designated assets.

_____ ___

.
(2)

Proceeds of debt issues.

_____ ___

.
(3)

Funds deposited with a trustee and
limited to use in accordance with
requirements of an indenture or similar
agreement.

_________

Other assets whose use is limited by an
arrangement between the provider and an
outside party other than a donor or
grantor (such as assets set aside to
meet depreciation funding requirements
or self-insurance funding agreements).
[AAG, par. 3.05]

_________

.
(4)

c.

Are agency funds (assets owned by others
under agency relationships such as
patients or physicians) and their related
liabilities reported in the general funds? _____ ___

d.

Are transactions involving receipt and
disbursement of agency funds excluded from

6

N/A

Yes
the results of operations?
[AAG, par. 3.06]
e.

Is property and equipment used for general
operations (and related liabilities)
reported in the general funds?

f.

Is property and equipment not used for
general operations (such as property
acquired for future expansion or
investment purposes) presented as a
separate item in the general funds?
[AAG, pars. 3.07 and 8.06]
Donor-restricted funds

2.

a.

Is donor-restricted property and equipment
(such as real estate investments of
endowment funds) reported in the
appropriate donor-restricted fund?
[AAG, pars. 3.07 and 8.07]

b.

Are resources restricted by donors for
additions to property and equipment
reported in restricted plant replacement
and expansion funds?

c.

Are plant replacement and expansion funds
reported in the statement of changes in
fund balances when expenditures are
incurred for the purpose intended by the
donor?
[AAG, par. 3.10]

d.

Do "term endowment funds" include
resources whose principal may be expended
after the donor-imposed time or after
other restrictions are satisfied?

e.

Is all pertinent information about term
endowment funds (such as term and
purposes) disclosed in the notes?

f.

Are term endowment funds available for
unrestricted purposes reported in the
statement of revenues and expenses?

g.

Are term endowment funds that became
7

No

N/A

Yes
available, but are further restricted
under the term endowment provisions, shown
as a reclassification to the appropriate
donor-restricted fund in the statement of
changes in fund balances?
[AAG, par. 3.11]
_____
h.

B.

Donated Funds Held in Trust
If donated resources are held in a trust (by
an independent trustee), of which the
provider is not the remainderman:

1.

a.

Are they excluded from the balance sheet?

_____

b.

Is their existence disclosed?
[AAG, par. 3.14]

_____

Has disclosure been considered of the right
to future income and the principal held in
trust?

2.

C.

Do endowment funds include resources whose
principal may not be expended?
[AAG, par. 3.13]
_____

3.

If the provider received a distribution,
was it reported in accordance with the terms
of the trust or agreement with the trustee?
[AAG, par. 3.15]

4.

If the provider is the remainderman, were
the donated funds reported as assets
(depending on the terms of the trust
document)?
[AAG, par. 3.16]
Financial Statements

1. For not-for-profit and governmental
providers, do the basic financial statements
include:
a.

A balance sheet?

b.

A statement of revenues and expenses of
general funds?

8

_____

No

N/A

Yes

2.

c.

A statement of changes in fund balances?

d.

A statement of cash flows of general funds
(and restricted funds of governmental
entities)?
_____
For investor-owned providers, are the basic
financial statements similar to those of
other investor-owned providers?
[AAG, par. 3.24]

_____

_____

CASH AND CASH EQUIVALENTS

II.

A.

General

1.

2.

_____

Are restrictions on cash (such as for plant
acquisition, debt reduction or working
capital maintenance) appropriately
disclosed?
[SFAS 5, pars. 18-19 (AC C59.120)]

_____

Personal Fund Accounts

B.
1.

2.

Are personal funds of patients, residents
and others under an agency arrangement,
reported as assets and corresponding
liabilities in the balance sheet?

Is the amount of personal funds reported as
assets disclosed parenthetically on the
balance sheet or in the notes?
[AAG, par. 5.06]
Cash Equivalents

C.

1.

III.

Is restricted cash appropriately segregated
from cash available for current operations?
[ARB 43, Ch. 3A, par. 6 (AC B05.107)]

Is the policy for determining cash
equivalents disclosed?
[SFAS 95, par. 10 (AC C25.108)]

INVESTMENTS

A.

General

1.

Are investments of general funds
9

_____

No

N/A

Yes

reported as current or noncurrent assets in
conformity with GAAP?
[AAG, par. 6.01]

B.

2.

Are the appropriate disclosures made for
investments in common stock accounted for by
the equity method?
[APB 18, par. 20 (AC I82.110)]

3.

Are other securities (such as real estate)
reported at amortized cost, or at lower of
cost or market if an impairment in value is
deemed to be other than temporary?
[AAG, par. 6.02c]
Marketable Equity Securities

1. For marketable equity securities do
disclosures include:

a.

For each balance sheet presented,
aggregate cost and market value (each
segregated between current and non-current
portfolios when a classified balance sheet
is presented) with identification as to
which is the carrying amount?

b.

For the latest balance sheet presented,
gross unrealized gains and gross
unrealized losses (each segregated between
current and noncurrent portfolios when
applicable)?
[SFAS 12, pars. 12b and 16a (AC I89.106b
and .110a)]

c.

For each period for which a statement of
revenues and expenses (statement of
operations) is presented:

.
(1)

Net realized gain or loss included in
the statement?

.
(2)

Basis on which cost was determined in
calculating realized gain or loss (such
as average cost or FIFO)?
[AAG, par. 6.09; SFAS 12, pars. 12 and
16 (AC I89.106 and .110)]

10

No

N/A

Yes

2.

Are significant net realized and net
unrealized gains and losses that arose after
the latest balance sheet date but before
issuance of the financial statements
disclosed?
[AAG, par. 6.10; SAS 1, sec. 560, pars. 5
and 7 (AU 560.05 and .07); SFAS 12, pars. 13
and 17 (AC I89.107 and .111); FASBI 11,
pars. 3-4 (AC I89.115-.116); FASBI 13, pars.
5-7 (AC I89.120-.122)]
_____

3.

Are losses due to a change in classification
of a marketable equity security between
current and noncurrent reported in the
statement of revenues and expenses?
[AAG, par. 6.12; SFAS 12, par. 10 (I89.104)] _____

4.

For a portfolio included in current assets
in the general funds, are changes in the
valuation allowance disclosed and reported
in the statement of revenues and expenses?

_____

For a portfolio included in noncurrent
assets, or assets in unclassified balance
sheets or restricted funds, are changes in
the valuation allowance disclosed and
reported in the respective statement of
changes in fund balances or equity?
[AAG, par. 6.12; SFAS 12, par. 11 (AC
I89.105)]

_____

5.

6.

Are realized gains or losses on the sale of
investments of endowment funds added to or
deducted from the funds’ principal (unless
such amounts are legally available for other
use or chargeable to other funds)?
[AAG, par. 6.13]
_____

7.

Are income and net realized gains or losses
on investments of restricted funds (other
than endowment funds) added to or deducted
from the respective fund balance (unless
such amounts were legally available for
other use or chargeable to other funds)?

_____

a. If such amounts are legally available for
unrestricted purposes, are they reported
in the statement of revenues and expenses? _____

11

No

N/A

Yes
b.

IV.

Are gains or losses on investment trading
between general and restricted funds and
between various categories of restricted
funds (such as between endowment and plant
expansion funds) separately disclosed in
the financial statements?
[AAG, par. 6.14]

RECEIVABLES

1.

Are charity care revenue and receivables
excluded from the financial statements?
[AAG, par. 7.02]

2.

Are differences between the estimates
originally reported and final settlements:
a.

Included in the statement of revenues and
expenses (statement of operations) in the
period the settlements are made?

b.

Reported in the current period unless they
meet the criteria for prior period
adjustments?
[AAG, par. 7.09; SFAS 16 (AC A35)]

3.

Are advances from third-party payers
reported as a liability (unless the right of
setoff against a related receivable
applies)?
[AAG, par. 7.11]

4.

Are deposits received from individuals
reported as a liability (to the extent that
a right of setoff does not exist)?
[AAG, par. 7.12]

5.

Are receivables (less an allowance for
uncollectibles, discounts, and contractual
adjustments) reported as current assets in
the general funds?

a. If the terms of payment have been extended
beyond one year from the balance sheet
date, has that portion been classified as
noncurrent?

12

No

N/A

Yes
b. Has consideration been given to
segregating amounts due from third-party
payors for retroactive adjustments of
items such as final settlements or
appeals?
AAG, par. 7.16
If financial statements present assets and
liabilities by fund groups:

6.

a.

Are interfund receivables or payables
reported separately by fund?

b.

In a classified balance sheet, are they
reported as current or noncurrent in
general funds?

7.

If financial statements do not present
assets and liabilities by fund groups, have
interfund receivables and payables been
eliminated?

8.

Have circumstances and terms of formal
interfund borrowing agreements been
disclosed?
AAG, par. 7.17

9.

Are pledges reported in the period in which
they were made?

a.

Are pledges reported net of an allowance
for uncollectible amounts?

b.

Are unrestricted pledges reported in the
statement of revenues and expenses
statement of operation?

c.

If a portion of a pledge is to be applied
during some future period, was that part
reported in the general fund in the period
in which it was received as deferred
revenue or, if restricted, as an addition
to donor-restricted funds?

d.

If pledges were restricted in any other
way, are they reported as additions to
donor-restricted funds?
AAG, par. 7.18

13

No

N/A

Yes

V.

10.

Are all receivables reported net of any
related allowance for uncollectible amounts
with appropriate disclosure?
[AAG, par. 7.19; APB 12, par. 3
(AC V18.102)]

11.

Are accounts and notes receivable from
officers, employees, and affiliated
organizations shown separately with
appropriate disclosures?
[ARB 43, Ch. 1A, par. 5 (AC R36.105)]

PROPERTY AND EQUIPMENT, SUPPLIES AND OTHER
ASSETS

1.

Has property acquired for future expansion
or investment been presented separately in
the general funds?
AAG, par. 8.06

2.

Has property and equipment of
donor-restricted funds (such as property
received as a donation to endowment funds)
been reported in the appropriate
donor-restricted fund?
AAG, par. 8.07

3.

Are donor or legal restrictions on the
proceeds from the disposition of property
and equipment disclosed?
AAG, par. 8.06

4.

For depreciable assets, do the financial
statements or notes disclose:
a.

Depreciation expense for each period?

b.

Balances of major classes of depreciable
assets by nature or function?

c.

Accumulated depreciation, either by major
classes of assets or in total?

d.

The method or methods used in computing
depreciation with respect to major classes
of depreciable assets?
[APB 12, par. 5 (AC D40.105)]
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No

N/A

Yes

5.

Are the costs of intangible assets acquired
from other entities recorded as assets?

6.

Are the costs of developing, maintaining or
restoring intangible assets which are not
specifically identifiable, have
indeterminate lives, or are inherent in a
continuing business and related to the
entity as a whole, expensed when incurred?
[APB 17, par. 24 (AC 160.105)]

_____

7.

Are issue costs of debt reported as deferred
charges?
[APB 21,
par. 16 (AC I69.109)]
_____

8.

Do disclosures include the method and period
of amortization of intangible assets?
[APB 22, par. 13 (AC A10.106)]
_____

9.

In a classified balance sheet:

a.

Have deferred tax assets been classified
as current or noncurrent based on the
classification of the related asset or
liability for financial reporting?
[SFAS 109, par. 41 (AC I27.140)]

_____

b.

Have deferred tax assets not related to an
asset or liability for financial reporting
(including those related to carryforwards)
been classified according to the expected
reversal date of the temporary difference?
[SFAS 109, pars. 41 and 288p (AC I27.140)] _____

c.

Has the valuation allowance for a
particular tax jurisdiction been allocated
between current and noncurrent deferred
tax asssets for that tax jurisdiction on a
pro rata basis?
[SFAS 109, par. 41 (AC I27.140)]
_____

d.

Have the following items been offset and
presented as a single amount for a
particular tax-paying component and within
a particular tax-paying jurisdiction:

(1).

All current deferred tax liabilities and
assets?
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No

N/A

Yes
(2).

All noncurrent deferred tax liabilities
and assets?
[SFAS 109, par. 42 (AC I27.141)]

10.

Have the totals of a) all deferred tax
assets and b) the related valuation
allowance recognized in the balance sheet
been disclosed?
[SFAS 109, par. 43 (AC I27.142)]

11.

Has an asset (prepaid pension cost) been
recognized if net periodic pension cost is
less than amounts the employer has
contributed to the plan?
[SFAS 87, par. 35 (P16.129)]

12.

If an additional minimum pension liability
has been recognized, has an equal amount
been recognized as an intangible asset,
provided that the asset recognized does not
exceed the amount of unrecognized prior
service cost?
[SFAS 87, pars. 36-37 (AC P16.130-.131)]

13.

Is the financial statement presentation of
supplies and other assets similar to that of
other business organizations?
AAG, par. 8.08

CURRENT LIABILITIES, NOTES PAYABLE AND OTHER
DEBT

VI.

Current Liabilities

A.
1.

Do current liabilities include:

a.

Obligations for items that have entered
the operating cycle?

b.

Collections received in advance of the
performance of services?

c.

Debts that arise from operations directly
related to the operating cycle?

d.

Other liabilities whose regular and
ordinary liquidation is likely to occur
within a relatively short time period?
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No

N/A

Yes
e.

Obligations that, by their terms, are due
on demand or will be due within one year
(or operating cycle, if longer) from the
balance sheet date, even though
liquidation may not be expected within
that period?
[ARB 43, Ch. 3A, pars. 7-8 (AC
B05.108-.109); SFAS 78, par. 5 (AC
B05.109A)]

2. Do current liabilities exclude short-term
obligations that the provider intends to
refinance on a long-term basis, provided the
provider has demonstrated the ability to
consummate the long-term financing?
[SFAS 6, pars. 8-14 (AC B05.112-.116);
FASBI 8 (AC B05.117 and .138-.139)]
Notes Payable and Other Debt

B.

1.

Is there adequate disclosure of interest
rates, maturities, and other terms and
conditions provided in loan agreements and
bond indentures (such as assets pledged as
collateral, and covenants to reduce debt,
and maintain working capital)?
[FASCON 5, par. 11; FASCON 1, par. 41; SFAS
5, par. 18 (AC C59.120); SAS 32, par. 2 (AU
431.02)]

2.

Are the combined aggregate amount of
maturities and sinking fund requirements for
all long-term borrowings disclosed for each
of the five years following the date of the
latest balance sheet presented?
[SFAS 47, par. 10b (AC C32.105b)]

3.

If the note is noninterest bearing or has an
inappropriate stated interest rate:
a.

Is the discount or premium presented as a
deduction from or addition to the face
amount of the note?

b.

Does the disclosure include the effective
interest rate and face amount of the note? _____

c.

Is amortization of the discount or premium
reported as interest expense?
_____
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No

N/A

Yes
d.

Are issue costs reported in the balance
sheet as deferred charges?
[APB 21, par. 16 (AC I69.109)]

4.

Are debt conversion features (such as rates
and pertinent dates) disclosed?
[FASCON 5, par. 11; FASCON 1, par. 41; APB
14, (AC D10); SAS 32, par. 2 (AU 431.02)]

5.

Are current portions of debt obligations
presented as current liabilities in a
classified balance sheet?
[ARB 43, Ch. 3A, pars. 7-8 (AC
B05.108-.109)]

6.

If a short-term obligation is to be excluded
from current liabilities in a classified
balance sheet, do disclosures include;
a.

General description of the financing
agreement?

b.

Terms of any new obligation incurred or
expected to be incurred, or equity
securities issued or expected to be issued
as a result of the refinancing?
[SFAS 6, par. 15 (AC B05.118)

For troubled debt restructuring occurring
during the current period, do disclosures
include:

7.

a.

Description of the principal changes in
terms and/or the major features of
settlement?

b.

Aggregate gain on restructuring of
payables and the related income tax
effect?

c.

Aggregate net gain or loss on transfers of
assets recognized during the period?

d.

Per share
aggregate
payables,
effect?
[SFAS 15,

amount, if applicable, of the
gain on restructuring of
net of related income tax
par. 25 (AC D22.121)]
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No

N/A

Yes
For periods after a troubled debt
restructuring, do disclosures include:

8.
a.

b.

Extent to which amounts contingently
payable are included in the carrying
amount of restructured payables?

_____

Total amounts contingently payable, if
applicable, and conditions under which
those amounts would become payable or
forgiven?
[SFAS 15, par. 26 (AC D22.122)]

_____

Has debt, as required, been considered
extinguished for financial reporting
purposes because:

9.

a.

b.

The debtor is legally released from being
the primary obligor, and it is probable
that the debtor will not be required to
make future payments with respect to that
debt under any guarantee?

_____

The debtor irrevocably places cash or
other assets in a trust to be used solely
for satisfying scheduled payments of both
interest and principal of a specific
obligation, and the possibility that the
debtor will be required to make future
payments with respect to that debt is
remote?
[SFAS 76, par. 3 (AC D14.102A)? TB 85-2
(AC C30)]

_____

10.

If there is an early extinguishment of debt,
is the difference between reacquisition
price and carrying amount identified as a
separate or extraordianry item?
[SFAS 4, par. 8 and SFAS 64, par. 4 (AC
D14.105)]
_____

11.

If debt is considered to be extinguished
early, do disclosures include:
a.

A general description of the transaction?

b.

The amount of debt that is considered
extinguished as long as the debt remains
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_____

No

N/A

Yes
outstanding?
[SFAS 76, par. 6 (AC D14.108)]

Are long-term obligations that are or will
be callable by the creditor, either because
the debtor’s violation of the debt agreement
at the balance sheet date makes the
obligation callable, or because the
violation (if not cured within a specified
grace period) will make the obligation
callable, classified as current unless one
of the following conditions is met:

12.

a.

The creditor has waived or subsequently
lost the right to demand repayment for
more than one year (or operating cycle, if
longer) from the balance sheet date?

b.

The obligation contains a grace period
within which the debtor may cure the
violation and it is probable that the
violation will be cured within that
period, thus preventing the violation from
becoming callable?
[SFAS 78, par. 5 (AC B05.109A)]

13.

Did the not-for-profit provider report
tax-exempt obligations that were issued for
its benefit as liabilities in the general
funds?
[AAG, par. 9.04]

14.

Has consideration been given to the effects,
if any, of current and prior tax
examinations on the financial statements and
disclosures related to the existence of
contingent liabilities for unrelated
business income tax, additional payroll tax
liabilities, or penalties and interest on
delinquent taxes?

15.

Has disclosure been considered for any
changes in the provider’s activities that
could affect its tax-exempt status?

16.

Are disclosures appropriate regarding the
provider’s tax-exempt status and any other
significant tax matters?
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No

N/A

Yes

Is appropriate disclosure made if unrelated
business income tax has not been accrued on
income from:

17.

18.

VII.

a.

Debt-financed investments that are not
functionally related to the exempt
purpose?

b.

Certain related entities not engaged in an
exempt activity?

c.

Pharmacy operations in a medical building
for the convenience of physicians' private
patients?

d.

A gift shop, cafeteria or food shop that
the provider encourages the general public
(except patients, visitors and employees)
to use?

e.

A parking lot available to the general
public (except patients, visitors and
employees)?

Has consideration been given to disclosing
the effects of the Tax Reform Act of 1986
which added new arbitrage restrictions
regarding tax-exempt bonds?
[AAG, pars. 9.19-.33; SFAS 5, pars. 9-10 (AC
C59.108-.lll)]

COMMITMENTS AND CONTINGENCIES

A.

Uninsured Medical Malpractice Claims

1.

If a minimum amount of a probable loss
(usually associated with litigating or
setting malpractice claims) has been
accrued, is there disclosure as to a
reasonable possibility of an additional
potential loss in excess of the amount
accrued?

2.

If a range of loss cannot be reasonably
estimated is a contingency disclosed?
[AAG, par. 10.04; SFAS 5(AC C59)]

3.

Are accrued unpaid claims and expenses
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No

N/A

Yes

4.

expected to be paid during the normal
operating cycle classified as current
liabilities?

__

Is the program of medical malpractice
coverage and basis for loss accruals
disclosed?
[AAG, par. 10.11; SFAS 5(AC C59)]

_____

If the provider discounts accrued
malpractice claims, are the following
disclosed?

5.

a.

The carrying amount of the claims.

_____

b.

The interest rates or other rates used to
discount the claims.
AAG, par. 10.12

_____

Retrospectively Rated Premiums

B.
1.

2.

If the provider cannot estimate losses from
asserted or unasserted malpractice claims,
is the existing contingency disclosed?
[AAG, par. 10.14; SFAS 5(AC C59)]

_____

Has the provider disclosed that it is
insured under a retrospectively rated
policy?

_____

3.

Has the provider disclosed that premiums are
accrued based on the ultimate cost of the
experience to date of a group of entities?
_____

4.

If losses cannot be estimated, is the
existing contingency disclosed?
[AAG, par. 10.15; SFAS 5(AC C59)]

_____

Medical Malpractice Claims Insured With
Captive Insurance Companies (Controlled by a
parent entity for the main purpose of
providing insurance for the parent.)

C.

1.

Has the provider disclosed that it is
insured under a retrospectively rated policy
of a multiprovider captive?
_____

2.

Has the provider disclosed that premiums are
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No

N/A

_____ ____

Yes
accrued based on the captive’s experience to
date?
AAG, par. 10.18

D.

3.

Is the provider's ownership percentage in
the captive disclosed?

4.

Is the method of accounting for its
investment in and the operations of the
captive disclosed?
[AAG, par. 10.19]

5.

If the provider cannot make the necessary
estimates of losses from asserted or
unasserted claims, Has it disclosed the
existing contingency?
[AAG, par. 10.19; SFAS 5 (AC C59)]

Trust Funds
1. If trust funds (revocable or irrevocable)
are included in the provider's financial
statements;
a.

Is a portion of the funds (the amount of
assets expected to be liquidated to pay
malpractice claims classified as current
liabilities) classified as a current asset
in a classified balance sheet?

b.

Is the balance of the funds, if any,
classified as a noncurrent asset in a
classified balance sheet?

c.

Are trust fund revenue and administrative
expenses included in the statement of
revenues and expenses (statement of
operations)?
[AAG, par. 10.20]

d.

Are estimated losses from asserted and
unasserted claims reported?
[AAG, par. 10.21]

e.

Is the existence of trust funds and
whether they are irrevocable disclosed?
[AAG, par. 10.22]
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No

N/A

Yes
Prepaid Health Care Services

E.

Health Care Costs

1.
a.

Is the basis for accruing health care
costs disclosed?

b.

Are significant business and contractual
arrangements with hospitals, physicians,
and other associated entities disclosed?
[SOP 89-5 (AAG, app. B), par. 32]

2.

F.

Stop-Loss Insurance

a.

Are receivables representing amounts
recoverable from insurers reported as
assets net of any valuation allowance?

b.

Are the nature, amounts, and effects of
significant stop-loss insurance contracts
disclosed?
[SOP 89-5 (AAG, app. B), par. 49]

Other Disclosures
1.

Are the nature and, if applicable, amount
(or a statement that no loss estimate can be
made) disclosed for loss contingencies
(including guarantees)?
[SFAS 5, pars. 9-12 and FASBI 34, pars. 2-3
(AC C59.108-.114) ]

2.

Are gain contingencies adequately disclosed,
with care to avoid misleading implications
as to the likelihood of realization?
[SFAS 5, par. 17 (AC C59.118)]

3.

Are the nature, term, amount and other
required information disclosed for long-term
unconditional purchase obligations?
[SFAS 47, pars. 7 and 10a (AC C32.102 and
.105a)]

4.

Are disclosures adequate for other
commitments and contingencies that are
similar to those of other business
organizations?
[AAG, par. 10.25; SFAS 5, pars. 4, 7 and 18
(AC C59.118, .120 and .122)]
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No

N/A

Yes
NET ASSETS (EQUITY OR FUND BALANCES)

VIII.

Financial Statement Presentation

A.
1.

Are the equity accounts of investor-owned
providers accounted for similarly to other
investor-owned businesses?

2.

Are the net assets of not-for-profit and
governmental providers (that use the
disaggregated method) displayed as general
and donor-restricted fund balances?

3.

Are the net assets of not-for-profit and
governmental providers (that use the
aggregated method) displayed as
unrestricted, temporarily restricted or
permanently restricted fund balances as
appropriate?
[AAG, par. 11.01]

4.

Is the nature of restrictions on
donor-restricted resources disclosed?
[AAG, par. 11.02]

5.

Shareholders' Equity (Corporations)
a.

For each class of stock, do disclosures
include the number of shares authorized,
issued and outstanding, and par or stated
value per share?
[APB 4, par. 199, R-9A]

b.

Do the financial statements include a
description, in summary form, sufficient
to explain the pertinent rights and
privileges of the various securities
outstanding, for example: dividend and
liquidation preferences, participation
rights, call prices and dates, conversion
or exercise prices or rates and pertinent
dates, sinking fund requirements, unusual
voting rights?
[APB 15, par. 19 (AC E09.110)]

c.

Are liquidation preferences of preferred
stock issues prominently disclosed in the
equity section of the balance sheet in the
aggregate?
[APB 10, par. 10 (AC C16.101)]
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No

N/A

Yes
d.

.
(1)

.
(2)

e.

For preferred stock, do disclosures
include:
Aggregate or per share amounts at which
shares may be called or are subject to
redemption?
[APB 10, par. 11 (ACC16.102)]

_____

Aggregate and per share amounts of
arrearages in cumulative preferred
dividends?
[APB 15, par. 50, fn. 16 (AC C16.102)]

_____

For stock option and stock purchase plans,
do disclosures include:

.
(1)

Number of shares under option?

_____

.
(2)

Option price?

_____

.
(3)

Number of shares as to which options are
exercisable?
_____

.
(4)

For options exercised, the number of
shares involved and option price?
[ARB 43, Ch. 13B, par. 15 (AC C47.123)]

f.

g.

h.

i.

_____

Are any appropriations of retained
earnings for loss contingencies clearly
identified and included in stockholders’
equity?
[SFAS 5, par. 15 (AC R70.103)]

_____

Are restrictions on payment of dividends
disclosed?
[SFAS 5, pars. 18-19 (AC C59.120)]

_____

Are receivables for stock issued or
subscribed appropriately identified and
presented as a deduction from capital or,
if presented as an asset, stated
separately, clearly labeled, and their
status clearly described to distinguish
them from any other type of assets?

_____

Are the amounts of redemption requirements
for all issues of capital stock that are
redeemable at fixed or determinable prices
26

No

N/A

Yes
on fixed or determinable dates disclosed
for each of the five years following the
date of the latest balance sheet
presented?
[SFAS 47, par. 10 (AC C32.105)]

Changes in Net Assets (Fund Balances)

6.

When both financial position and results
of operations (or revenue and expenses of
general funds) are presented:

a.

.
(1)

Are changes in the separate component
accounts of equity (or fund balances)
disclosed?
[APB 12, par. 10 (AC C08.102); AAG, par.
3.24]

.
(2)

Are changes in the number of shares of
capital stock disclosed for at least the
latest year and any subsequent interim
periods presented?
[APB 12, par. 10 (AC C08.102)]

b.

Are prior period adjustments and their
resulting effects (both gross and net of
applicable income taxes) appropriately
presented and disclosed?
[APB 9, par. 26 (AC A35.107)]

c.

If an additional pension liability is
required to be recognized and exceeds
unrecognized prior service cost, has the
excess (which would represent a net loss
not yet recognized as net periodic pension
cost) been reported as a separate
component (that is, a reduction) of equity
net of any tax benefits that result from
considering such losses as temporary
differences?
[SFAS 87, par. 37 (AC P16.131)]

REVENUES, EXPENSES, GAINS AND LOSSES

IX.

Conceptual Framework for Reporting and
Classification

A.
1.

Are revenues and expenses (arising from
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No

N/A

Yes

ongoing activities associated with health
care services) classified as operating and
displayed as gross amounts?
2.

Has display of gains and losses [resulting
from peripheral or incidental transactions
and from other events (environmentally
related and largely uncontrollable)] as net
amounts been considered?
[AAG, pars. 12.01 -.02]

3.

Are gains and losses classified in relation
to major ongoing or central operations such
as:
a.

Operating if related?

b.

Nonoperating if peripheral, incidental or
unrelated?
[AAG, sec. 12.03]

4.

For investments in common stock accounted
for by the equity method, is the investor's
share of earnings shown as a single amount
except for investee extraordinary items and
prior period adjustments that are material
to the investor?
[APB 18, pars. 19c-d (AC I82.109c-d)]

5.

Are total research and development costs
charged to expense disclosed for each period
to which a statement of revenues and
expenses [operations] is presented?
[SFAS 2, pars. 12-13 (AC R50.108-.109)?
FASBI 4, par. 5 (AC B50.152); FASBI 6, par.
8 (AC R50.117); SFAS 68, par. 14 (AC
R55.112); SFAS 86, par. 3 (AC Co2.102)]

6.

Is the amount of interest cost incurred
disclosed in the statements or notes
thereto, and for an accounting period in
which some interest cost is capitalized, the
total amount thereof that has been
capitalized?
[SFAS 34, par. 21 (AC I67.118)]

7.

If there is a compensatory stock issuance
plan, are disclosures adequate?
[ARB 43, Ch. 13B, par. 15 (AC C47.123)]
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No

N/A

Yes
8. If the provider accounts for its obligation
under a research and development arrangement
as a contract to perform research and
development for others, is there disclosure
of:
a.

The terms of significant agreements under
the research and development arrangement
as of the date of each balance sheet
presented?

b.

The amount of compensation earned or costs
incurred under such contracts for each
period for which a statement of revenues
and expenses [statement of operations] is
presented?
[SFAS 68, par. 14 (AC R55.112)]

Revenue

B.

1.

Is revenue classified based on the type of
service (such as patient or resident)
rendered or contracted to be rendered?
[AAG, par. 12.04]

2.

Are contributions, tax support and other
subsidies classified as:
a.

Gains, when peripheral or incidental to
health care activities?

b.

Revenues, if deemed ongoing major or
central activities to provide health care
services?
[AAG, par. 12.05]

3.

4.

Is other revenue (such as from sales and
services, other than health care, to
patients, residents, nonpatients or
visitors):

a.

Classified as operating?

b.

Stated separately?
[AAG, pars. 12.06 -.07]

Have gains and losses been properly
classified and reported?
[AAG, par. 12.08]
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No

N/A

Yes
Financial Statement Presentation

C.

1.

Is service revenue reported net of
contractual charity care and other
adjustments?
[AAG, par. 12.11]

2.

Do disclosures include the methods of:
a.

Revenue recognition?

b.

Recording unrestricted and restricted
donations and investment income of both
general and restricted funds?

3.

With regard to contractual adjustments and
third-party settlements, did the provider
identify and explain the estimated amounts
payable or receivable?
[AAG, par. 12.13]

4.

Are expenses incurred to solicit
contributions separately disclosed?
[AAG, par. 12.16]

5.

Income Taxes
a.

Have the types of significant temporary
differences and carryforwards been
disclosed?
[SFAS 109, par. 43 (AC I27.142)]

b.

Are the following significant components
of income tax expense attributable to
continuing operations for each year
presented disclosed in the financial
statements or notes thereto?

.
(1)

Current tax expense or benefit.

.
(2)

Deferred tax expense or benefit
(exclusive of the effects of other
components listed below).

.
(3)

Investment tax credits.

.
(4)

Government grants (to the extent
recognized as a reduction of income tax
expense).
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No

N/A

Yes

.
(5)

The benefits of operating loss
carryforwards .

.
(6)

Tax expense that results from allocating
certain benefits either directly to
contributed capital or to reduce
goodwill or other noncurrent intangible
assets of an acquired entity.

.
(7)

Adjustments of a deferred tax liability
or asset for enacted changes in tax laws
or rates or a change in the tax status
of the provider.

.
(8)

Adjustments of the beginning-of-the-year
balance of a valuation allowance because
of a change in circumstances that causes
a change in judgment about the
realizability of the related deferred
tax asset in future years.
[SFAS 109, par. 45 (AC I27.144)]

c.

Are the amount of income tax expense or
benefit allocated to continuing operations
and the amounts separately allocated to
other items disclosed for each year for
which those items are presented?
[SFAS 109, pars. 35-39 and 46 (AC
I27.134-.138 and .145)]

d.

Is the nature of significant reconciling
items disclosed?
[SFAS 109, par. 47 (AC I27.146)]

e.

Are the amounts and expiration dates of
operating loss and tax credit carry
forwards for tax purposes disclosed?
[SFAS 109, par. 48 (AC I27.147)]

f.

If the provider is a member of a group
that files a consolidated tax return, are
the following items disclosed in its
separately issued financial statements:

.
(1)

The aggregate amount of current and
deferred tax expense for each period
presented, and the amount of any
tax-related balances due to or from
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No

N/A

Yes
affiliates as of the date of each
balance sheet presented.

.
(2)

6.

The method by which the consolidated
amount of current and deferred tax
expense is allocated to members of the
group and the nature and effect of any
changes in that method (and in
determining related balances to or from
affiliates) for each period presented.
[SFAS 109, par. 49 (AC I27.148)]

g.

Is the effect of initially applying SFAS
109 [AC I27] reported as the effect of a
change in accounting principle in a manner
similar to the cumulative effect of a
change in accounting principle, except for
initially recognized tax benefits of the
type required to be excluded from
comprehensive income.
[APB 20, par. 20 (AC A06.116); SFAS 109,
par. 51]

h.

When initially presented, have the
financial statements for the year SFAS 109
[AC I27] is first adopted disclosed the
following:

.
(1)

The effect, if any, of adopting SFAS 109
on continuing operations before income
taxes (for example, the effect of
adjustments for prior purchase business
combinations and for regulated
enterprises) for the year of adoption if
restated financial statements for the
prior year are not presented?

.
(2)

The effect of any restatement on
continuing operations, income before
extraordinary items, and net income (and
related per share amounts, if
applicable) for each year for which
restated financial statements are
presented?
[SFAS 109, par. 52]

Discontinued Operations
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No

N/A

Yes
a.

Are operations of a segment that has been
discontinued or is the subject of a formal
plan for disposition:

.
(1)

Reported separately from continuing
operations and as a component (including
applicable income taxes) of operations
before extraordinary items?
_____

.
(2)

Accompanied by disclosure in the notes
of revenue applicable to the
discontinued operations?

_____

b.

Is gain or loss from disposal of a
discontinued segment reported separately
(including applicable income taxes) in
conjunction with results of discontinued
operations as a component of income before
extraordinary items?
[APB 30, pars. 8, 13 and 15-18 (AC
I13.101-.103 , .105-.106 and .108-.109)]
_____

c.

For the period encompassing the
measurement date, do notes to financial
statement disclose:

.
(1)

Identity of the segment discontinued?

_____

.
(2)

Expected disposal date, if known?

_____

.
(3)

Expected manner of disposal?

_____

.
(4)

Description of the remaining assets and
liabilities of the discontinued segment
at the balance sheet date?

.
(5)

Results of operations and any proceeds
from disposal of the discontinued
segment during the period from the
measurement date to the balance sheet
date?
[APB 30, par. 18 (AC I13.108-.109)]

d. For periods after the measurement date and
including the disposal, do notes to
financial statements disclose the
information required for the period
encompassing the measurement date and the
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No

N/A

Yes

actual date and results of disposal
compared with the prior estimates?
[APB 30, par. 18 (AC I13.108-.109)]

7.

Extraordinary Items
a.

Do extraordinary items meet both criteria
of (1) an unusual nature and (2)
infrequency of occurrence?
[APB 30, pars. 19-24 (AC I17.106-.lll and
.118)]

b.

Are extraordinary items segregated and
shown (including applicable income taxes)
after income before extraordinary items
and before net income?
[APB 30, par. 10-12 (AC I17.102-.103)]

c.

Are descriptive captions and amounts
(including applicable income taxes)
presented for individual extraordinary
events or transactions, preferably on the
face of the income statement, if
practicable?

d.

Do disclosures include descriptions of
extraordinary events or transactions and
the principal items entering into
determination of extraordinary gains or
losses?
[APB 30, par. 11 (AC I17.102)]

e.

For gains or losses from extinguishment of
debt classified as extraordinary items, do
disclosures include:

.
(1)

Description of the extinguishment
transactions, including the sources of
any funds used to extinguish the debt if
it is practicable to identify the
sources?

.
(2)

Income tax effect in the period of
extinguishment?

.
(3)

Per share amount (if applicable) of the
aggregate gain or loss net of related
income tax effect?
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No

N/A

Yes

[SFAS 4, pars. 8-10 (AC I17.104 and
D14.105-.107) ]

_____

For an adjustment of an extraordinary item
reported in a prior period (except for
correction of an error):

f.

.
(1)

(2)

Is the adjustment classified separately
as an extraordinary item in the current
period?

_____

Are the nature, origin and amount of the
item disclosed?
[SFAS 16, par. 16(c) (AC I17.119)]
_____

Are material events or transactions that are
either unusual in nature or of infrequent
occurrence but not both (and therefore not
meeting criteria for extraordinary items):

8.

a.

Reported as a separate component of income
from continuing operations?
_____

b.

Accompanied by disclosure of the nature
and financial effects of each event?
[APB 30, par. 26 (AC I22.101)]

_____

X. STATEMENT OF CASH FLOWS
Is a statement of cash flows presented as a
basic financial statement for each period for
which a statement of revenues and
expenses (statement of operations) is
presented for:

A.

General funds of a not-for-profit or
governmental entity?

_____

2.

Restricted funds of a governmental entity?

_____

3.

Any investor-owned entity?
[SFAS 95, par. 3 (AC C25.101); AAG, pars.
3.24-.25]

_____

Does the statement of cash flows explain the
effect of cash flows by showing the change in
cash and cash equivalents?
[SFAS 95, par. 7 (AC C25.105)]

_____

1.

B.

35

No

N/A

Yes

C.

Is the policy for defining cash equivalents
disclosed?
[SFAS 95, par. 10 (AC C25.108)]

D.

If the direct method is used, has a
reconciliation of the excess of revenues and
expenses [income] to net cash flow from
operating activities been provided in a
separate schedule?
[SFAS 95, par. 30 (AC C25.128)]

E.

If the indirect method is used:

1.

Has the same amount for net cash flow from
operating activities been reported
indirectly by adjusting the excess of
revenues and expenses [income] to reconcile
it to net cash flow from operating
activities?
[SFAS 95, par. 28 (AC C25.126)]

2.

Has the reconciliation of the excess of
revenues and expenses [income] to net cash
flow from operating activities been reported
either within the statement of cash flows or
provided in a separate schedule, with the
statement of cash flows reporting only the
net cash flow from operating activities?
[SFAS 95, par. 30 (AC C25.128)]
Are cash receipts and cash payments for the
following transactions classified as cash
flows from operating activities:

F.

1.

Interest received on loans?

2.

Insurance proceeds except those directly
related to investing or financing
activities?

3.

Interest paid to creditors?

4.

Payments to suppliers and employees?

5.

Payments to governments for taxes, duties,
fines, and other fees or penalties?

6.

Payments to settle lawsuits?
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No

N/A

Yes

7.

Contributions to charities?
[SFAS 95, pars. 22-23 (AC C25.120-.121)]
Are cash receipts and cash payments for the
following transactions classified as cash
flows from investing activities:

G.

1.

Receipts from collections or sales of loans? _____

2.

Receipts from sales of property?

_____

3.

Loans to others?

_____

4.

Payments to acquire property?
[SFAS 95, pars. 16-17 (AC C25.114-.115)]

Are cash receipts and cash payments for the
following transactions classified as cash
flows from financing activities:

H.

1.

Proceeds from issuing debt?

2.

Repayments for amounts borrowed?
[SFAS 95, pars. 19-20 (AC C25.117-.118)]

I.

Except for certain items whose turnover is
quick, amounts are large and maturities are
short, are cash receipts and cash payments
from investing and financing activities shown
separately on the statement of cash flows?
[SFAS 95, pars. 12-13 and 31 (AC C25.110-.lll
and .129)]

J.

Are noncash investing and financing activities
(such as converting debt to equity) summarized
in a separate schedule or the notes?
[SFAS 95, par. 32 (AC C25.134)]
RELATED ORGANIZATIONS AND ECONOMIC DEPENDENCY

XI.

A.

Business Combinations
If a business combination occurred during
the period and met the specified conditions
for a pooling of interests:
[APB 16, pars. 45-48 (AC B50.104-.107)]

1.

a.

Has the required accounting method been
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No

N/A

Yes
applied?
[APB 16, pars. 50-62 (AC B50.109-.121)]
b.

2.

3.

B.

Do the statements and notes include the
required disclosures?
[APB 16, pars. 63-65 (AC B50.122-.124)]

_____

If a business combination does not meet the
specified conditions for a pooling of
interests:
a.

Has the combination been accounted for by
the purchase method?
[APB 16, pars. 66-88 and 90-94 (AC
B50.125-.146 and .159-.163); SFAS 87,
pars. 74, 253 and 387 (AC B50.146j and 1);
SFAS 106, pars. 86-88 (AC B50.106k);
SFAS 109, pars. 288d and q (AC B50.1461
and .148); SFAS 38 (AC B50.148-.150);
FASBI 4, pars. 4-5 (AC B50.151-.152)]
_____

b.

Do the statements and notes include the
required disclosures as applicable?
[APB 16, pars. 95-96 (AC B50.164-.165);
SFAS 79, par. 6 (AC B50.165); SFAS 38,
par. 10 (AC B50.166)]

_____

Has any portion of the valuation allowance
for deferred tax assets for which
subsequently recognized tax benefits will be
allocated to reduce goodwill or other
noncurrent intangible assets of an acquired
entity, or directly to contributed capital
been disclosed?
[SFAS 109, pars. 30, 36 and 48 (AC I27.129,
.135 and .147)]
_____
Consolidation and Combination

1. If the provider and another entity are
related and they meet the criteria for
consolidation or combination
("consolidation”), are consolidated or
combined ("consolidated") financial
statements presented?
[AAG, par. 13.2; ARB 51 (AC C51); SFAS 94
(AC C51)]
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_____

No

N/A

Yes

2.

If consolidated statements are presented:
a.

Is the consolidation policy disclosed?
[ARB 51, par. 5 (AC C51.108); APB 22, par.
13 (AC A10.106)]

b.

Are intercompany balances and transactions
eliminated?
[ARB 51, par. 6 (AC C51.109)]

c.

When the financial reporting periods of
consolidated entities differ, is
recognition given, by disclosure or
otherwise, to the effect of intervening
events that materially affect financial
position or results of operations?
[ARB 51, par. 4 (AC C51.107); SFAS 12,
pars. 18-20 (AC I89.112-.114); FASBI 13,
pars. 6-8 (AC I89.120-.122)]

3.

If the parent company has realized gains or
losses of marketable securities in
operations and a consolidated subsidiary
does not, has the subsidiary’s accounting
treatment for marketable securities been
conformed with that of the parent?
[SFAS 12, par. 18 (AC I89.112)]

4.

If the parent follows specialized accounting
practices for marketable securities and the
consolidated subsidiaries do not, are the
subsidiaries' current and noncurrent
portfolios consolidated as separate current
and noncurrent portfolios exclusive of the
parent and is the required information
disclosed?
[SFAS 12, pars. 12 and 19 (AC I89.106 and
.113)]

5.

If the consolidated financial statements
include more than one accepted practice of
accounting for marketable securities, are
the required disclosures made for the
various methods?
[SFAS 12, par. 20 (AC I89.114)]

6.

Do disclosures about formerly unconsolidated
subsidiaries, that are now consolidated,
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No

N/A

Yes

include summarized information about the
assets, liabilities, and results of
operations (or separate statements) in the
consolidated financial statements or notes?
[AAG, par. 13.2; SFAS 94, par. 14 (AC
C51.120A)]
Related Parties and Economic Dependency

C.
1.

If the entity does not meet the criteria for
consolidation or combination, but controls
and is the sole beneficiary of a related
organization’s activities, is summarized
financial data of the related organization
disclosed?
[AAG, pars. 13.3-.4]

2.

For any related party that is not
consolidated or combined, did the entity
disclose (even if there are no transactions
between them):
a.

The nature of the relationship between the
entity and the related party?

b.

If there have been material transactions
between the entity and the related party:

.
(1)

A description of the transactions,
including transactions to which nominal
or no amounts were ascribed?

.
(2)

The amount of such transactions?

.
(3)

Amounts due from or to the related party
and, if not apparent, the terms and
manner of settlement?
[AAG, pars. 13.03-.05; SFAS 13, par. 29
(AC L10.125); SFAS 57, pars. 2-4
(AC R36.102-.104)]

CONTINUING CARE RETIREMENT COMMUNITIES (CCRCs)

XII.

Refundable Advance Fees

A.
1.

Is the estimated amount of advance fees
expected to be refunded to current residents
reported as a liability?
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No

N/A

Yes

B.

2.

Is the remaining amount of advance fees
reported in the balance sheet as deferred
revenue?

3.

Are the following disclosed:
a.

The gross amount of contractual refund
obligations under existing contracts?

b.

The CCRC’s refund policy?

4.

Are amounts refunded disclosed in the
statement of cash flows as a financing
transaction?
[SOP 90-8 (AAG, app. C), par. 22]

5.

Is the method of accounting, including the
amortization method, for deferred revenue
disclosed?
[AAG, par. 9.34; SOP 90-8 (AAG, app. C),
pars. 23, 31 and 43]
Fees Refundable to Residents Only From
Reoccupancy Proceeds of a Contract Holder’s
Unit

1. Are the following reported as deferred
revenue:

C.

a.

The portion of fees to be paid to current
residents or their designees, only to the
extent of a contract holder’s unit
reoccupancy proceeds, if law and
management policy and practice support the
withholding of refunds under this
condition?

b.

Similar amounts received from new
residents in excess of the amount to be
paid to previous residents or their
designees?
[SOP 90-8 (AAG, app. C), par. 31]

Nonrefundable Advance Fees

1. Are nonrefundable advance fees reported as
deferred revenue?
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Yes
Is unamortized deferred revenue reported as
revenue upon a resident’s death or contract
termination?
[SOP 90-8 (AAG, app. C), pars. 23 and 43]

2.

Obligation to Provide Future Services and Use
of Facilities to Current Residents

D.

If the obligation to provide future services
and use of facilities to current residents
under continuing-care contracts results in a
liability, are the following disclosed:

1.

a.

The carrying amount of the liability?

b.

The interest rate used to discount that
liability?
[SOP 90-8 (AAG, app. C), par. 55]

Costs of Acquiring Initial Continuing-Care
Contracts

E.

1.

Are costs of acquiring initial
continuing-care contracts capitalized if
they are expected to be recovered from
future contract revenues?

2.

Are continuing-care contract acquisition
costs expensed if incurred after a) the CCRC
is substantially occupied or b) one year
following completion?
[SOP 90-8 (AAG, app. C), par. 63]

FINANCIAL STATEMENTS AND NOTES - GENERAL

XIII.

Titles and References

A.
1.

Are the financial statements suitably
titled?
[SAS 62, par. 7 (AU 623.07)]

2.

Does each statement include a general
reference that the notes are an integral
part of the financial statement
presentation?

3.

Do the note captions and the referencing
from the applicable statement
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No

N/A

Yes
classifications seem appropriate?
[FASCON, par. 18]

Disclosure of Accounting Policies

B.
1.

Is a description of all pertinent accounting
policies of the provider presented as an
integral part of the financial statements?
[APB 22, pars. 8-9 (AC A10.102-.103)]

2.

Does disclosure of significant accounting
policies encompass important judgments as to
appropriateness of principles concerning
recognition of revenue, and allocation of
asset costs to current and future periods?
[APB 22, par. 12 (AC A10.105)]

3.

Does the disclosure of significant
accounting policies include appropriate
reference to details presented elsewhere (in
the statements and notes thereto) so
duplication of details is avoided?
[APB 22, par. 14 (AC A10.107)]
Accounting Changes

C.

For an accounting change, does disclosure in
the period of the change include:

1.
a.

Nature of the change?

b.

Justification for the change including a
clear explanation why the newly adopted
principle is preferable?

c.

Effect on income?
[APB 20, par. 17 (AC A06.113)]
For changes in accounting principle
(excluding specific exceptions related to an
initial public offering, change in the
reporting entity, or adoption of certain
authoritative pronouncements):

2.

a.

If comparative financial statements are
included, are they presented as previously
reported?
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No

N/A

Yes
b.

Is the cumulative effect of the change
(direct effects and income tax effects
only) on beginning retained earnings for
the period of the change shown in the
statement of revenues and expenses
[statement of operations] of that period,
after any extraordinary items and before
net revenue and gains in excess of
expenses and losses [net income]?

c.

Is the effect of adopting the new
accounting principle on revenue and gains
in excess of expenses and losses [income]
before extraordinary items and net revenue
and gains in excess of expenses and losses
[net income] (and applicable per share
data) disclosed for the period of the
change?

d.

Are pro forma revenues and gains in excess
of expenses and loss [income] before
extraordinary items and net revenue and
gains in excess of expenses and losses
[net income] shown on the face of the
statement of revenue and expenses
[statement of operations] for all periods
presented as if the newly adopted
accounting principle had been applied
during all periods affected?

e.

If pro forma amounts or cumulative effects
cannot be determined, are the reasons
disclosed?
[APB 20, pars. 12, 17-22, 24-26, 29 and 34
(AC A06.113-.118, .120-.122 and .125, and
A35.112 and .114); FASBI 20, par. 5
(A06.127)]

Is the correction of an error shown as a
prior period adjustment with disclosure of
the following in the period of its discovery
and correction:

3.

a.

Nature of the error in previously issued
financial statements?

b.

Effect of its correction on revenue and
gains in excess of expenses and losses
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No

N/A

Yes

[income] before extraordinary items and
net revenue and gains in exces of expenses
and losses [net income] (and related per
share amounts if applicable)?
[APB 20, par. 36 (AC A35.105); SFAS 109,
par. 288n (ACA35.103)]

D.

Comparative Financial Statements
1.

Have comparative statements been considered?
[ARB 43, Ch. 2A, pars. 1-2 (AC F43.101.102)]

2.

Are the notes and other disclosures included
in the financial statements of the preceding
year(s) presented, repeated or at least
referred to, to the extent that they
continue to be of significance?
[ARB 43, Ch. 2A, par. 2 (AC F43.102)]

3.

If changes have occurred in the manner of or
basis for presenting corresponding items for
two or more periods, are appropriate
explanations of the changes disclosed?
[ARB 43, Ch. 2A, par. 3 (AC F43.103)]
Financial Instruments

E.

Except for certain excluded items [SFAS 105,
pars. 14-15 (AC F25.104-.105)], are the
following disclosed in the financial
statements or notes for each class of
financial instruments with off-balance-sheet
risk?

1.

a.

The face or contract amount, or notional
principal amount if there is no face or
contract amount?

b.

The nature and terms, including, at a
minimum, a discussion of:

.
(1)

Credit and market risk of those
instruments?

.
(2)

Cash requirements of those instruments?

.
(3)

Related accounting policy, as required
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_____

No

N/A

Yes

by APB 22, Disclosure of Accounting
Policies (AC A10)?
[SFAS 105, par. 17 (CT F25.112)]

_____

For financial instruments with
off-balance-sheet credit risk [except for
the items excluded in SFAS 105, (AC F25)],
are the following disclosed either in the
financial statements or in the notes by
class of financial instrument?

2.

a.

The amount of accounting loss the entity
would incur if 1) any party to the
financial instrument failed completely to
perform according to the terms of the
contract, and 2) the collateral or other
security, if any, for the amount due
proved to be of no value to the entity.

_____

Regarding collateral or other security to
support financial instruments subject to
credit risk:

b.

.
(1)

The entity’s policy of requiring such
collateral or other security.

_____

.
(2)

Information about the entity’s access to
that collateral or other security.
_____

.
(3)

The nature and a brief description of
the collateral or other security
supporting those financial instruments.
[SFAS 105, par. 18 (AC F25.113)]

_____

Do disclosures of all significant
concentrations of credit risk arising from
all financial instruments, whether from an
individual counterparty or groups of
counterparties (except for certain insurance
and investment contracts, purchase and
pension obligations and substantively
extinguished debt), include:

3.

a.

b.

Information about the (shared) activity,
region, or economic characteristic that
identifies the concentration?
The amount of the accounting loss due to
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_____

No

N/A

Yes
credit risk the entity would incur if 1)
parties to the financial instruments that
make up the concentration failed
completely to perform according to the
terms of the contracts and 2) the
collateral or other security, if any, for
the amount due proved to be of no value to
the entity?

Regarding collateral or other security to
support financial instruments subject to
credit risk:

c.

.
(1)

The entity’s policy of requiring such
collateral or other security?

.
(2)

Information about the entity's access to
that collateral or other security?

.
(3)

The nature and a brief description of
the collateral or other security
supporting those financial instruments?
[SFAS 105, pars. 14 and 20 (AC F25.104
and .115)]

4.

Is the fair value of financial instruments
for which it is practicable to estimate that
value (except for certain excluded items
and trade receivables and payables whose
amount approximates fair value)
disclosed
in the financial statements or accompanying
notes?

5.

Are the methods and significant assumptions
used to estimate the fair value of financial
instruments disclosed?
[SFAS 107, par 10 (AC F25.115C)]

6.

If it is not practicable to estimate the
fair value of a financial instrument, are
the following disclosed?
a.

Information pertinent to estimating the
fair value of that financial instrument or
class of financial instruments, such as
the carrying amount, effective interest
rate, and maturity.
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No

N/A

Yes
b.

The reasons why it is not practicable
estimate fair value.
[SFAS 107, par. 14 (AC F25.115G)]

to

Nonmonetary Transactions

F.

1. Do disclosures include:

Nature of the transactions?

b.

Basis of accounting for the assets
transferred?

c.

Gains or losses recognized on the
transfers?
[APB 29, par. 28 (AC C11.102 and N35.120)]

Subsequent Events

G.

H.

a.

1.

Are the financial statements adjusted for
any changes in estimates resulting from
subsequent events that provide additional
evidence about conditions that existed at
the balance sheet date?
[SFAS 5, par. 8 (AC C59.105); SAS 1, secs.
560.03-.04, .07 and 561.01-.09 (AU
560.03-.04, .07 and 561.01-.09)]

2.

Are subsequent events that provide evidence
about conditions that did not exist at the
date of the balance sheet but arose
subsequent to that date adequately disclosed
to keep the financial statements from being
misleading?
[SFAS 5, par. 11 (AC C59.112); APB 16 (AC
B50.120); SAS 1, secs. 560.05-.07, .09 and
561.01-.09 (AU 560.05-.07, .09 and
561.01-.09)]

Pension Plans
1. If there is a defined benefit plan, do
disclosures include:
a.

A description of the plan, including
employee groups covered, type of benefit
formula, funding policy, types of assets
held and significant nonbenefit
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No

N/A

Yes
liabilities, if any, and the nature and
effect of significant matters affecting
comparability of information for all
periods presented?
b.

The amount of net periodic pension cost
for the period showing separately the
service cost component, the interest cost
component, the actual return on assets for
the period, and the net total of other
components?

c.

A schedule reconciling the funded status
of the plan with amounts reported in the
employer's balance sheet, showing
separately:

.
(1)

The fair value of plan assets?

.
(2)

The projected benefit obligation
identifying the accumulated benefit
obligation and the vested benefit
obligation?

.
(3)

The amount of unrecognized prior service
cost?

.
(4)

The amount of unrecognized net gain or
loss (including asset gains and losses
not yet reflected in market-related
value)?

.
(5)

The amount of any remaining unrecognized
net obligation or net asset existing at
the date of initial application of SFAS
87 [AC P16]?

.
(6)

The amount of any additional liability
recognized pursuant to SFAS 87,
paragraph 36 [AC P16.130]?

.
(7)

The amount of net pension asset or
liability recognized in the balance
sheet pursuant to SFAS 87, paragraphs
35-36 [AC P16.129-.130] (which is the
net result of combining the preceding
six items)?
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No

N/A

Yes
d.

The weighted-average assumed discount rate
and rate of compensation increase (if
applicable) used to measure the projected
benefit obligation and the
weighted-average expected long-term rate
of return on plan assets?

e.

If applicable, the amount and types of
securities of the employer and related
parties included in plan assets, and the
approximate amount of annual benefits of
employees and retirees covered by annuity
contracts issued by the employer and
related parties. Also, if applicable, the
alternative amortization methods used
pursuant to SFAS 87, paragraphs 26 and 33
[AC P16.120 and .127], and the existence
and nature of the commitment discussed in
paragraph 41 [AC P16.135]?
[SFAS 87, par. 54 (AC P16.150)]

f.

If more than one defined benefit plan
exists:

.
(1)

Have the disclosures required by Step
H.1. above been aggregated for all of
the employee’s single-employer defined
benefit plans or disaggregated in groups
so as to provide the most useful
information?

.
(2)

Are plans with assets in excess of
accumulated benefit obligations not
aggregated with plans that have
accumulated benefit obligations that
exceed plan assets?
[SFAS 87, par. 56 (AC P16.153)]

If there are one or more defined
contribution plans, do disclosures include:

2.

a.

A description of the plans including
employee groups covered, the basis for
determining contributions, and the nature
and effect of significant matters
affecting comparability of information for
all periods presented?
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No

N/A

Yes

b.

The amount of cost recognized during the
period?
[SFAS 87, par. 65 (AC P16.162)]

3.

If the substance of a plan having
characteristics of both defined benefits and
contributions is to provide a defined
benefit, are disclosures in accordance with
the requirements applicable to a defined
benefit plan as described in Step H.1.
above?
[SFAS 87, par. 66 (AC P16.163)]

4.

If there are one or more multiemployer
plans, do disclosures include:
a.

A description of the multiemployer plans
including the employee groups covered, the
type of benefits provided (defined benefit
or defined contribution) , and the nature
and effect of significant matters
affecting comparability of information for
all periods presented?

b.

The amount of cost recognized during the
period?
[SFAS 87, par. 69 (AC P16.166)]

If there is a settlement and/or curtailment
of a defined benefit pension plan and/or
termination benefits under such plan, do
disclosures include:

5.

a.

A description of the nature of the
event(s)?

b.

The amount of gain or loss recognized?
[SFAS 88, par. 17 (AC P16.187)]

Postretirement Benefits Other Than Pensions

I.

If there are one or more defined benefit
postretirement plans, do disclosures
include:

1.

a.

A description of the substantive plans
that is the basis for the accounting,
including the nature of the plans, any
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No

N/A

Yes

modifications of the existing cost-sharing
provisions that are encompassed by the
substantive plans, and the existence and
nature of any commitment to increase
monetary benefits provided by the plans,
employee groups covered, types of benefits
provided, funding policy, types of assets
held and significant nonbenefit
liabilities, and the nature and effect of
significant matters affecting the
comparability of information for all
periods presented, such as the effect of a
business combination or divestiture?

b.

The amount of net periodic postretirement
benefit cost showing separately the
service cost component, the interest cost
component, the actual return on plan
assets for the period, amortization of the
unrecognized transition obligation or
transition asset, and the net total of
other components?

c.

A schedule reconciling the funded status
of the plans with amounts reported in the
employer’s balance sheet, showing
separately:

.
(1)

The fair value of plan assets?

.
(2)

The accumulated postretirement benefit
obligation, identifying separately the
portion attributable to retirees, other
fully eligible plan participants, and
other active plan participants?

.
(3)

The amount of unrecognized prior service
cost?

.
(4)

The amount of unrecognized net gain or
loss (including plan asset gains and
losses not yet reflected in
market-related value)?

.
(5)

The amount of any remaining unrecognized
transition obligation or transition
asset?
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No

N/A

Yes

.
(6)

d.

The amount of net postretirement benefit
asset or liability recognized in the
balance sheet, which is the net result
of combining the preceding five items?
_____

The assumed health care cost trend rates
used to measure the expected cost of
benefits covered by the plan (gross
eligible charges) for the next year and a
general description of the direction and
pattern of change in the assumed trend
rate(s) thereafter, together with the
ultimate trend rate(s) and when the rate
is expected to be achieved?

e.

The weighted-average of the assumed
discount rate(s) and rate(s) of
compensation increase (for pay-related
plans) used to measure the accumulated
postretirement benefit obligation and the
weighted-average of the expected long-term
rate(s) of return on plan assets and, for
plans whose income is segregated from the
employer’s investment income for tax
purposes, the estimated income tax rate(s)
included in that rate of return?

f.

The effect of a one-percentage-point
increase in the assumed health care cost
trend rates for each future year on:

_____

.
(1)

The aggregate of the service and
interest cost components of net periodic
postretirement health care benefit cost? _____

.
(2)

The accumulated postretirement benefit
obligation for health care benefits (for
purposes of this disclosure, all other
assumptions shall be held constant and
the effects shall be measured based on
the substantive plan that is the basis
for the accounting)?
_____

g.

The amounts and types of securities of the
employer and related parties included in
plan assets, and the approximate amount of
future annual benefits of plan
participants covered by insurance
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N/A

Yes

contracts issued by the employer and
related parties?
h.

Any alternative amortization method used?
[SFAS 106, pars. 53 or 60, and 74 (AC
P40.148 or .155, and .169)]?

i.

The amount of gain or loss recognized
during the period for a settlement or
curtailment and a description of the
nature of the event(s)?

j.

The cost of providing special or
contractual termination benefits
recognized during the period and a
description of the nature of the event(s)?
[SFAS 106, par. 74 (AC P40.169)]
If more than one defined benefit
postretirement plan exists:

2.

3.

a.

Have the disclosures been aggregated for
all of an employer’s single-employer
defined benefit postretirement plans or
disaggregated in groups so as to provide
the most useful information (except that
the aggregate plan assets and the
aggregate accumulated postretirement
benefit obligation of the underfunded
plans shall be separately disclosed)?
[SFAS 106, par. 77 (AC P40.172)]

b.

Are plans that provide primarily
postretirement healthcare benefits and
plans that provide primarily other
postretirement welfare benefits separately
disclosed if the accumulated
postretirement benefit obligation of the
latter plans is significant relative to
the aggregate accumulated postretirement
benefit obligation for all of the plans?
[SFAS 106, par. 78 (AC P40.173)]
If there is a multiemployer plan, do
disclosures include:

a. A description of the multiemployer plan(s)
including the employee groups covered, the
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No

N/A

Yes

type of benefits provided (defined benefit
or defined contribution), and the nature
and effect of significant matters
affecting comparability of information for
all periods presented?
b.

The amount of postretirement benefit cost
recognized during the period, if
available.
Otherwise, the amount of the
aggregate required contribution for the
period to the general health and welfare
benefit plan that provides health and
welfare benefits to both active employees
and retirees?
[SFAS 106, par. 82 (AC P40.178)]

4. If there are one or more defined
contribution postretirement plans, have the
following items been disclosed separately
from defined benefit postretirement plan
information:

J.

a.

A description of the plan(s) including
employee groups covered, the basis for
determining contributions, and the nature
and effect of significant matters
affecting comparability of information for
all periods presented?

b.

The amount of cost recognized during the
period?
[SFAS 106, par. 106 (AC P40.198)]

Segment Information

1. If required, does the financial statement
presentation include segment information?
[SFASs 14 and 21 (AC S20); SFAS 24, pars.
4-5 (AC S20.109-.110) ; SFAS 30, par. 6 (AC
S20.145); TBs 79-4 and 79-5 (AC S20.501.504)]

Lessors

K.

1.

Are lessor disclosures appropriate and
adequate?
[SFAS 13, pars. 23, 29 and 47, and SFAS 91,
par. 25d (AC L10.119, .125 and .149)]
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No

N/A

Yes
Lessees

L.

For capital leases do disclosures include:

1.

a.

b.

c.

_____

Future minimum lease payments as of the
date of the latest balance sheet
presented, in total and for each of the
next five years, with separate deductions
for executory costs and imputed interest
to reduce net minimum lease payments to
present value?

_____

Total future minimum sublease rentals
under noncancelable subleases as of the
date of the latest balance sheet
presented?

_____

d.

Total contingent rentals actually incurred
for each period presented?
_____

e.

Assets recorded under capital leases and
the related accumulated amortization, and
obligations under those leases identified
separately in the balance sheet or a note?
[SFAS 13, pars. 13 and 16 (AC L10.112a)]
_____

For operating leases that have initial or
remaining noncancelable lease terms in
excess of one year, do disclosures include:

2.

3.

Gross amounts of assets recorded by major
classes as of the date of each balance
sheet presented?

a.

Future minimum rental payments required as
of the latest balance sheet presented in
total and for each of the next five years? _____

b.

Total future minimum rentals under
noncancelable subleases as of the date of
the latest balance sheet presented?
[SFAS 13, par. 16b (AC L10.112b)]

_____

For all operating leases do disclosures
include rental expense for each period
presented, with separate amounts for minimum
rentals, contingent rentals, and sublease
rentals?
[SFAS 13, par. 16c (AC L10.112c)]
_____
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No

N/A

Yes

4. Do disclosures include a general description
of the lessee's leasing arrangements
including but not limited to:

a.

Bases for determination of contingent
rentals?

b.

Terms of any renewal or purchase options
or escalation clauses?

c.

Restrictive covenants?
[SFAS 13, par. 16d (AC L10.112d)]

Other Liabilities and Deferred Credits

M.

If the entity is subject to income taxes:

1.

a.

Have deferred tax liabilities been
classified as current or noncurrent based
on the related asset or liabil
ity for
financial reporting?
[SFAS 109, par. 41 (AC I27.140)]

b.

Have deferred tax liabilities not related
to an asset or liability for financial
reporting been classified according to the
expected reversal date of the temporary
difference pursuant to SFAS 37?
[SFAS 109, par. 41 (AC I27.140)]

c.

Have the following items been offset and
presented as a single amount for a
particular tax-paying component and within
a particular tax-paying jurisdiction:

.
(1)

All current deferred tax liabilities and
assets?

.
(2)

All noncurrent deferred tax liabilities
and assets?
[SFAS 109, par. 42 (AC I27.141)]

d.

Have the components of the total of all
deferred tax liabilities recognized in the
balance sheet been disclosed?
[SFAS 109, par. 43 (AC I27.142)]

e.

Has the following information been
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No

N/A

Yes

disclosed whenever a deferred tax
liability is not recognized because of the
exceptions to comprehensive recognition of
deferred taxes for any of the areas
addressed by APB 23 (as amended by SFAS
109):

.
(1)

A description of the types of temporary
differences for which a deferred tax
liability has not been recognized and
the types of events that would cause
those temporary differences to become
taxable?

.
(2)

The cumulative amount of each type of
temporary difference?

.
(3)

The amount of the unrecognized deferred
tax liability for temporary differences
related to investments in foreign
investees that is essentially permanent
in duration if determination of that
liability is practicable or a statement
that the determination is not
practicable?

.
(4)

The amount of the unrecognized deferred
tax liability for certain other
temporary differences?
[SFAS 109, pars. 31-32 and 44 (AC
I27.130-.131 and .143)]
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REPORTING CHECKLISTS
These checklists have been developed by the staff of the Technical
Information Division of the AICPA as nonauthoritative practice aids.
For an explanation of the references used in these checklists, see
page 5 of this publication.
Yes

No

N/A

AUDIT REPORTS

A.

Does the auditor’s report include appropriate:

1.
a.

b.
c.

2.

3.

Title that includes the word ’’independent”?
[SAS 58, par. 8 (AU 508.08)]

_______________

Addressee?
[SAS 58, par. 9 (AU 508.09)]

_______________

Date (or dual dates) of the report?
[SAS 1, sec. 530 (AU 530); SAS 26, pars. 15-17
(AU 504.15-.17); SAS 58, par. 74
(AU 508.74)]

_______________

If the accountant is not independent, regardless
of the extent of services provided, has the
appropriate disclaimer been expressed? [SAS 26,
pars. 8-10 (AU 504.08-.10) or SSARS 1, pars. 22
and 38 (AR 100.22 and .38)]

_______________

Does the reporting language conform with the
auditor’s standard report on single-period or
comparative financial statements, whichever
applies?
[SAS 58, par. 8 (AU 508.08)]

_______________

Does the report include appropriate language in
respect of the following:

4.
a.

Report on only one basic financial statement and
there are no scope limitations?
[SAS 58, pars. 47-48 (AU 508.47 -.48)]
_______________

b.

Report on comparative statements of revenues and
expenses [statements of operations], fund
balances [retained earnings], and cash flows of
general funds [cash flow], without presentation
of the comparative balance sheets for the prior
years?
[SAS 58, par. 8, fn. 7 (AU 508.08, fn. 7)]
_______________
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Yes

c.

Part of the audit was made by other
independent auditors, and the principal
auditors are indicating a division of
responsibility for the audit in their
report?
[SAS 1, sec. 543 (AU 543); SAS 58, pars. 12-13
(AU 508.12-.13), SAS 64, par. 3 (AU 543.16)]

d.

Departure from a promulgated accounting
principle when conformity would result in a
misleading presentation?
[SAS 58, pars. 14-15 (AU 508.14 -.15)]

e.

Updating of a previously issued report?
[SAS 58, par. 78 (AU 508.78)]

f.

Comparative financial statements with differing
opinions?
[SAS 58, pars. 74-76 (AU 508.74 -.76)]

g.

Audited and unaudited financial statements in
comparative form?
[SAS 26, pars. 14-17 (AU 504.14-.17)]

h.

Decision to emphasize a matter?
[SAS 58, par. 37 (AU 508.37)]

5.

Has explanatory language been added to the
auditor’s report if:
a.

The financial statements are affected by
uncertainties concerning future events, the
outcome of which is not susceptible of
reasonable estimation at the date of the
auditor's report?
[SAS 58, pars. 16-33 (AU 508.16-.33)]

b.

The auditor concludes that there is substantial
doubt about the provider's ability to continue
as a going concern for a reasonable period of
time and that conclusion is expressed through
the use of the phrase, "substantial doubt about
the provider's ability to continue as a going
concern"?
[SAS 64, par. 1 (AU 341.12-.13)]

c.

There has been a material change between periods
in accounting principles or in the method of
their application?
[SAS 58, pars. 34-36 (AU 508.34-.36)]
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No

N/A

Yes

d.

e.

f.

In an updated report on comparative financial
statements, the current opinion on the prior
period is different from the one
previously expressed?
[SAS 58, pars. 77-78 and 81-83
(AU 508.77-.78 and .81-.83)]

____

Other information in a document containing
audited financial statements is materially
inconsistent with information appearing in the
financial statements?
[SAS 8 (AU 550)]

____

The auditor wishes to emphasize a matter
regarding the financial statements?
[SAS 58, par. 37 (AU 508.37)]

____

If the financial statements of a prior period have
been audited by a predecessor auditor whose report
is not presented, did the successor auditor
indicate in the introductory paragraph:

6.

The financial statements of the prior period
were audited by another auditor?

____

b.

The date of the predecessor auditor’s report?

____

c.

The type of report issued by the predecessor
auditor?

____

a.

d. If the report was other than a standard report,
the substantive reasons therefor?
[SAS 64, par. 2 (AU 508.83)]
7.

If the financial statements have been restated
does the introductory paragraph indicate that a
predecessor auditor reported on the financial
statements of the prior period before restatement?
[SAS 64, par. 2 (AU 508.83)]

8.

If the successor auditor was engaged to audit and
applied sufficient procedures to satisfy himself
or herself as to the appropriateness of the
restatement adjustments, did he or she report on
the adjustments?
[SAS 64, par. 2 (AU 508.83)]

9.

If, following a pooling-of-interests transaction,
an auditor is engaged to report on restated
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No

N/A

Yes

financial statements for one or more prior years
when other auditors audited one or more of the
entities included in such financial statements,
did he or she include appropriate explanatory
language?
[SAS 64, par. 3 (AU 543.16)]

10.

Has a qualified opinion or disclaimer of opinion
been expressed if scope limitations precluded
application of one or more auditing procedures
considered necessary in the circumstances?
[SAS 58, pars. 40-45 (AU 508.40-.45);
SAS 31, par. 23 (AU 326.23)]

11.

Has a qualified opinion or adverse opinion been
expressed because of a lack of conformity with
GAAP (including inadequate disclosure)?
[SAS 32, par. 3 (AU 431.03); SAS 34, par. 11 (AU
340.11); SAS 58, pars. 49-66
(AU 508.49-.66); SAS 54, par. 18 (AU 317.18)]

12.

If a qualified opinion, adverse opinion or
disclaimer of opinion is expressed, are all the
substantive reasons for the opinion or disclaimer
disclosed?
a.

Is the reporting language clear and appropriate?
[SAS 58, pars. 38-72 (AU 508.38 -.72)]

Does the report include modification, if
applicable, for the following:

13.
a.

Conditions that precluded application of
necessary auditing procedures to opening
long-term investments?
[SAS 58, par. 42 (AU 508.42)]

b.

Regulated companies?
[SAS 1, sec. 544.02 -.04 (AU 544.02 -.04); SAS
62, pars. 2-10 (AU 623.02-.10)]

c.

Client representations about related party
transactions that are unsubstantiated by
management?
[SAS 45, par. 12 (AU 334.12)]

d.

Client’s refusal to provide written
representations?
[SAS 19, par. 11 (AU 333.11)]
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No

N/A

Yes
e.

Limitations on scope of lawyer’s response?
[SAS 12, pars. 12-14 (AU 337.12-.14)]

f.

Unresolved matters involving specialists?
[SAS 11, par. 9 (AU 336.09)]

g.

Financial statements materially affected by an
irregularity?
[SAS 53, par. 26 (au 316. 26)]

h.

Illegal acts by clients?
[SAS 54 (AU 317)]

i.

Segment information?
[SAS 21 (AU 435)]

j.

Material misstatement of the financial
statements?
[SAS 47, par. 31 (AU 312.31)]

k.

Financial statements issued before the effective
date of a Statement of Financial Accounting
Standards when disclosure is not made of the
effect of a restatement which will be required
in the future as a result of the Statement?
[Interpretation 3 of SAS 1, section 410 (AU
9410.13-.19)]

14.

Has a piecemeal opinion been avoided?
[SAS 62, par. 14 (AU 623.14); SAS 58,
par. 73 (AU 508.73)]

15.

If information accompanies the basic financial
statements in an auditor-submitted document:
a.

Is there a clear distinction between the
client’s representations and auditor's
representations?
[SAS 29, par. 20 (AU 551.20)]

b.

Does the auditor's report on the accompanying
information:

.
(1)

State that the audit was made for the purpose
of forming an opinion on the basic financial
statements taken as a whole?

.
(2)

Specifically identify the accompanying
information?
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No

N/A

Yes

.
(3)

State that the accompanying information is
presented for purposes of analysis and is not
part of the basic financial
statements?

.
(4)

State whether the additional information has
been subjected to the auditing procedures
applied in auditing the basic financial
statements and the appropriate expression of
opinion or disclaimer?
[SAS 29, pars. 6-11 (AU 551.06 -.11)]

16.

If an auditor-submitted document with accompanying
information (long-form report) is coexisting with
a document that includes just the basic financial
statements and auditor’s report:
a.

Do the basic financial statements in all
coexisting documents consistently include all
the information necessary for a fair
presentation in conformity with GAAP?
[SAS 29, par. 21 (AU 551.21)]

b.

Are any additional comments or
explanations by the auditor consistent
with the description of the scope of the
audit in the auditor's standard (or modified)
report?
[SAS 29, par. 20 (AU 551.20)]

17.

If the document contains interim financial
information, has the auditor’s report been
expanded if required?
[SAS 71, pars. 30-34 (AU 722.30 -.34)]

18.

If supplementary information required by the FASB
is presented outside the basic financial
statements in an auditor-submitted document, has
an opinion been disclaimed on such information
unless it has been audited?
[SAS 29, par. 7 (AU 551.07); SAS 27, pars. 8 and
11 (AU 553.08 and .11)]

19.

Reportable conditions in the internal
control structure must be communicated,
preferably in writing, to the audit committee
or to individuals with equivalent
responsibility and authority [SAS 60, pars.
1-2 (AU 325.01 -.02)].
If a report on
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N/A

Yes

internal accounting control is to be issued,
is the appropriate form used for:
a.

Expression of an opinion on the entity’s system
of internal accounting control in effect as of a
specified date or during a specific period of
time?
[SAS 30, pars. 37-46 (AU 642.37 -.46)]
____

b.

Reporting on significant deficiencies or other
appropriate matters regarding the internal
control structure that were noted during an
audit?
[SAS 60 (AU 325.04-.06)]

____

Reports for restricted use of management and
specified regulatory agencies, based on the
regulatory agencies’ pre-established criteria?
[SAS 30, pars. 54-59 (AU 642.54 -.59)]

____

Other special purpose reports on all or part of
an existing or proposed system for
restricted use of management or specified third
parties?
[SAS 30, pars. 60-61 (AU 642.60 -.61) SAS 44,
pars. 35, 41 and 46 (AU 324.35, .41, and .46)]

____

c.

d.

If reporting in a client-prepared document on
condensed financial statements (either for an
annual or an interim period) that are derived from
audited financial statements of a public entity
that is required to file, at least annually,
complete audited financial statements with a
regulatory agency, does the auditor’s report
indicate:

20.

a.

That an audit was performed and an opinion
expressed on the complete financial
statements?

b.

The date of the report on the complete financial
statements?

c.

The type of opinion expressed?

d.

Whether, in the auditor's opinion, the
information set forth in the condensed
financial statements is fairly stated in
all material respects in relation to the
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No

N/A

Yes
complete financial statements from which
it has been derived?
[SAS 42, par. 5 (AU 552.05)]

____

21.

If a statement that names the auditor, and states
that condensed financial statements have been
derived from audited financial statements, is made
in a client-prepared document that does not
include complete audited financial statements, and
the client is not a public entity that is required
to file complete audited financial statements with
a regulatory agency at least annually, does the
auditor•s report express an adverse opinion on the
condensed financial statements because of
inadequate disclosure?
[SAS 42, par. 7, fn. 6 (AU 552.07, fn. 6); SAS 58,
pars. 55-58 (AU 508.55-.58)]
____

22.

If reporting on selected financial data that are
included in a client-prepared document that
contains audited financial statements (or, with
respect to a public entity, that incorporates such
statements by reference to information filed with
a regulatory agency) and that are derived from
audited financial statements, does the auditor’s
report indicate the following:

That they have audited and expressed an opinion
on the complete financial statements?

____

b.

The type of opinion expressed?

____

c.

The specific data on which they are reporting?

____

d.

Whether, in their opinion, the information
set forth in the selected financial data is
fairly stated in all material respects in
relation to the complete financial statements
from which it has been derived?

____

a.

23. If the selected financial data for any of the
years presented are derived from financial
statements that were audited by another
independent auditor, does the auditor’s report on
the selected financial data state that fact and
express a disclaimer of opinion on that data?
[SAS 42, par. 9 (AU 552.09)]
B.

COMPILATION AND REVIEW REPORTS
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No

N/A

Yes

For compiled financial statements, does the report
state that:

1.
a.

A compilation has been performed in accordance
with Statements on Standards for Accounting and
Review Services issued by the American Institute
of Certified Public Accountants?
[SSARS 7, par. 5]

b.

A compilation is limited to presenting in the
form of financial statements information that is
the representation of management (owners)?
[See SSARS 3, par. 3 (AR 300.03) for different
wording that may be used when the financial
statements are included in a prescribed form and
the form or related instructions call for
departures from generally accepted accounting
principles.]

c.

The financial statements have not been audited
or reviewed and, accordingly, the accountant
does not express an opinion or any other form of
assurance on them?
[SSARS 1, par. 14 (AR 100.14); SSARS 5, par. 1
(AR 500.01)]

For reviewed financial statements, does the report
state that:

2.
a.

A review was performed in accordance with
Statements on Standards for Accounting and
Review Services issued by the American Institute
of Certified Public Accountants?
[SSARS 7, par. 5]

b.

All information included in the financial
statements is the representation of the
management (owners) of the provider?

c.

A review consists principally of inquiries of
organization personnel and analytical procedures
applied to financial data?

d.

A review is substantially less in scope than an
audit, the objective of which is the expression
of an opinion regarding the financial statements
taken as a whole and, accordingly, no such
opinion is expressed?
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No

N/A

Yes

e. The accountant is not aware of any material
modifications that should be made to the
financial statements in order for them to be in
conformity with GAAP or, where applicable, with
an other comprehensive basis of accounting,
other than those modifications, if any,
indicated in the report?
[SSARS 1, par. 32 (AR 100.32)]

3.

For compiled and reviewed financial statements,
does the report exclude a description of any other
procedures that the accountant might have
performed before or during the engagement?
[SSARS 1, pars. 14 and 32 (AR 100.14 and .32)]

4.

If compiled financial statements omit substan
tially all disclosures required by GAAP, does the
accountant’s report clearly indicate such
omission?
[SSARS 1, pars. 19 and 21 (AR 100.19
and .21)]

5.

If compiled financial statements include
disclosures about only a few matters, are such
disclosures labeled "Selected Information—
Substantially All Disclosures Required by
Generally Accepted Accounting Principles Are Not
Included"?
[SSARS 1, par. 19 (AR 100.19)]

6.

If the financial statements are presented on a
basis of accounting other than GAAP, and the basis
of accounting is not disclosed, does the
accountant’s report disclose the basis of
accounting?
[SSARS 1, par. 20 (AR 100.20)]

7.

If the financial statements contain a departure
from GAAP or, where applicable, an other
comprehensive basis of accounting, does the
accountant’s report disclose the departure?
[SSARS 1, par. 39 (AR 100.39)]
a.

If the effects of the departure on the
financial statements have been determined
by management or are known as a result of
the accountant's procedures, are these
effects also disclosed in the modified report?

or
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N/A

Yes
b.

8.

9.

If the effects of the departure on the financial
statements have not been determined, has the
accountant’s report been modified to state this? ____
If the accountant is not independent with respect
to the provider for which financial statements
have been compiled, does the compilation report
state in the last paragraph, "We are (I am) not
independent with respect to XYZ Company"?
(Accountants are precluded from issuing a review
report if they are not independent.)
[SSARS 1, pars. 22 and 38 (AR 100.22
and .38)]

____

Is the report dated?

____

10.

Does each page of the financial statements include
a reference such as "See Accountant's Compilation
(Review) Report"?
[SSARS 1, pars. 16 and 34 (AR 100.16 and .34];
SSARS 2, par. 6 (AR 200.06)]
____

11.

When accompanying information is presented with
the financial statements, does the accountant's
report indicate degree of responsibility with
respect to such information?
{SSARS 1, par. 43 (AR 100.43)]

____

If an audit engagement has been changed to a
review or compilation, does the report omit
reference to;
a) the original engagement, b) any
auditing procedures that may have been performed,
and c) any scope limitation that resulted in the
changed engagement?
[SSARS 1, par. 49 (AR 100.49)]

____

12.

For comparative financial statements:

13.

a.

b.

Does the accountant's report cover each period
presented?
[SSARS 2, par. 2 (AR 200.02)]
If compiled financial statements that omit
substantially all of the disclosures required by
GAAP are presented with the comparative
financial statements, do all the periods
presented also omit such disclosures, and does
the accountant's compilation report include an
additional paragraph that indicates:
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____

No

N/A

Yes
The nature of the previous service rendered
(compilation, review or audit)?

____

.
(2)

Date of the previous reports?

____

.
(3)

Appropriate language in accordance with SSARS
No. 1, paragraphs 19-20 and SSARS 2, paragraph
30?
[SSARS 1, pars. 19-21 (AR 100.19-.21);
SSARS 2, pars. 5 and 29-30 (AR 200.05 and
.29-.30)]
____

.
(1)

c.

d.

.
(1)

.
(2

e.

If the level of service performed by the
continuing accountant on the current-period
financial statements is the same or higher than
that performed on the financial statements of
the prior period presented, has the continuing
accountant's report on the prior period been
updated?
[SSARS 2, pars. 8-10 (AR 200.08 -.10)]

____

If the level of service performed by the
continuing accountant on the current-period
financial statements is lower than that
performed on the financial statements of the
prior period presented:

Does the report on the current period include
a separate paragraph that describes the
responsibility assumed for the prior period?

____

Is the report on the current period
accompanied by or combined with a reissued
report on the financial statements of the
prior period presented?
[SSARS 2, pars. 8, 11 and 12 (AR 200.08 and
.11-.12)]

____

If the report requires a changed reference to a
departure from GAAP regarding the prior period
presented, does the explanatory paragraph in the
report include:

.
(1)

The date of the previous report?

____

.
(2)

Description of the circumstances or events
underlying the change?

____

.
(3)

Indication that the prior-period financial
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N/A
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statements have changed?
[SSARS 2, pars. 14-15 (AR 200.14 -.15)]
f.

If the predecessor accountant does not
reissue his or her compilation or review report
on the prior-period financial statements, has
the successor accountant made appropriate
reference in his or her report to the
predecessor’s report, or performed a
compilation, review, or audit of the statements
of the prior period and reported on them
accordingly?
[SSARS 2, pars. 16-19 (AR 200.16 -.19)]

g.

If the prior-period financial statements
presented have been changed, has the
predecessor or successor accountant reported
on them as presented?
[SSARS 2, pars. 25-26 (AR 200.25 -.26)]

h.

If the current-period financial statements were
compiled or reviewed and the prior period was
audited, and the audit report has not been
reissued, does the current-period report include
a separate paragraph that contains the
following:

.
(1)

Statement that the prior-period financial
statements were previously audited?

.
(2)

Date of the previous report?

.
(3)

Type of opinion previously expressed?

.
(4)

If the opinion was other than unqualified, the
substantive reasons therefor?

.
(5)

That no auditing procedures were performed
after the date of the previous report? [For
guidance on situations when the current period
is audited and the prior period is compiled or
reviewed, see Statement on Auditing Standards
No. 26 (AU 504)]
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No

N/A

Checklist for Auditors'
Reports on Audits Performed
Government Auditing Standards and Under OMB Circular A-1331

Under

This checklist has been developed by the staff of the Technical
Information Division of the AICPA as a nonauthoritative practice
aid.
This checklist has two parts: Part I is for reports on audits
performed under Government Auditing Standards ("Yellow Book").
Part II is for reports on audits performed under the Single Audit
Act in accordance with OMB Circular A-133.
For audits performed
under Circular A-133, both Parts I and II of this checklist must be
completed.
Explanation of References:

A-133 = Office of Management and Budget (OMB) Circular A-133
GAS = Government Auditing Standards ("Yellow Book", issued
by GAO, 1988 Revision)
SAS = Statement on Auditing Standards
AU = Reference to section number in AICPA Professional
Standards (vol. 1) of SAS cited
SOP 92-9 = AICPA Statement of Position, Audits of Not-for-profit
Organizations Receiving Federal Awards

1 On March 8, 1990, The Office of Management and Budget issued
Circular A-133, Audits of Institutions of Higher Education and
Other Nonprofit Institutions, to implement a "single audit" re
quirement for nonprofit institutions. Circular A-133 requires that
the auditor perform the audit in accordance with Government
Auditing Standards (the "Yellow Book") issued by the Comptroller
General of the United States.

Circular A-133, which supersedes the audit provisions of Circular
A-110, is effective for audits of fiscal years beginning on or
after January 1, 1990.
Because Circular A-133 permits biennial
audits, some institutions may not be required to follow its
requirements until the audits of their financial statements for the
fiscal year ending June 30, 1992.

SAS No. 68, Compliance Auditing Applicable to Governmental Entities
and Other Recipients of Governmental Financial Assistance, provides
guidance on planning, performing, and reporting on the compliance
aspects of audits in accordance with GAAS, GAO Standards, Circular
A-133, and Circular A-128, which applies to State and Local
Governmental entities.
On December 28, 1992 the AICPA issued SOP 92-9, Audits of Not-forProfit Organizations Receiving Federal Awards, to provide guidance
on the auditor's responsibilities when conducting an audit in ac
cordance with Circular A-133. It incorporates the guidance in SAS
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Footnote 1 (continued)

68, SOP 92-7, OMB's October 1991 Compliance Supplement for Audits
of Institutions of Higher Learning and Other Non-Profit Institu
tions, and the President's Council on Integrity and Efficiency
Standards Subcommittee's Position Statement No. 6 [A-133 Questions
and Answers].
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CHECKLIST QUESTIONNAIRE
Yes No N/A

Part I - REPORTS ON AUDITS PERFORMED IN ACCORDANCE
WITH GOVERNMENT AUDITING STANDARDS (THE "YELLOW
BOOK")

1.

In an audit performed in accordance with The
Yellow Book, were the following reports issued?
a.

A report on the provider's basic financial
statements:1

b.

A report on internal control structure:

A report on compliance with laws and regula
tions that may have a direct and material
effect on the basic financial statements?
[SOP 92-9, par. 7.2]

c.

2.

Does each auditor's report listed in step No. 1
that the audit was conducted in accordance with
generally accepted auditing standards and The
Yellow Book?
[GAS, Ch. 5, par. 3; SOP 92-9, par. 7.4]

Report on Internal Control Structure2
3.

Does the report on internal control
include, at a minimum:

structure

a.

The scope of the auditor's work to obtain an
understanding
of
the
internal
control
structure, and to assess control risk?

b.

The significant internal controls estab
lished to ensure compliance with laws and
regulations that have a material impact on
the financial statements?

c.

Any reportable conditions, including sepa
rate identification of material weaknesses,
identified as a result of the auditor's work
in understanding and assessing the control
risk?

d.

A statement that the report is intended for
the information of the audit committee,

1 See checklist for auditor's reports on the basic financial
statements beginning on page 59.
2
Under the Yellow Book, a report on the internal control
structure is required in all audits, even if no reportable
conditions were noted.
[SAS 68, par. 33 (AU 801.33)]
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Yes
management,
and specific legislative or
regulatory bodies, but that this restriction
is not intended to limit the distribution of
the report, if a matter of public record?
[GAS, Ch. 5, pars. 17 and 18; SAS 68, pars. 33
and 40 (AU 801.33 and .40)]
4.

If the auditor has noted reportable conditions
in the financial statement audit, does the audi
tor's report on the internal control structure
also contain:
a.

The definition of reportable conditions?

b.

A description of the reportable conditions
noted?

c.

The definition of material weakness?

If applicable, a statement that other
matters involving the internal controls
structure and its operation were communi
cated to management in a separate letter?
[SAS 68, par. 40 (AU 801.40)]

d.

5.

If material weaknesses were noted in the report,
did the auditor disclose the condition, cause,
criteria, and effect of those material weak
nesses?
[GAS, Chap. 5, par. 9, footnote 7]

6.

If the auditor determined that deficiencies in
the internal control structure are not signifi
cant enough to be considered reportable condi
tions (referred to as "nonreportable condi
tions"), have those matters been communicated to
the provider in writing (or orally, with working
paper documentation)?
[SAS 68, par. 39 (AU 801.39); GAS Chap. 5, par.
25]

7.

If
the
auditor
issues a separate written
communication
describing
nonreportable
conditions, does the auditor's report on the
internal
control
structure
refer
to
that
separate communication?
[SAS 68, pars. 38 and 39 (AU 801.38-.39); SOP
92-9, par. 7.12]

8.

If no reportable conditions were noted during
the audit, does the report disclose that no
material weaknesses were identified?
[SAS 68, par. 42 (AU 801.42), SOP 92-9, par.
7.11]
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No

N/A

Yes

No

N/A

Report on Compliance With Laws and Regulations
9.

Does the report on compliance with laws and
regulations conform to the standard report
illustrated in SAS 68, par. 25 (AU 801.25)?

10. If the auditor decided not to test compliance
with laws and regulations, does the report
contain a statement that compliance with laws
and regulations was not tested?
[SAS 68, par. 26 (AU 801.26) GAS, Chap. 5, par.
6]

11. If the auditing procedures disclosed material
instances of noncompliance, was the report on
compliance appropriately modified?
[SAS 68, par. 27 (AU 801.27)]
a.

Does that modified report include:
(1)

The definition and identification of
material instances of noncompliance
noted?

statement that the noncompliance noted
was considered in forming an opinion on
whether the provider's financial state
ments are presented fairly, in conformity
with generally accepted accounting
principles?
[SAS 68, par. 27 (AU 801.27)]

(2)

12. If the
report contains material instances of
noncompliance, was a statement considered about:
a.

Whether
rected?

the

misstatements

have

been

cor

or

The effect of such misstatements on the
auditor's report on the basic financial
statements?
[SAS 68, par. 28 (AU 801.28)]

b.

13. Are
immaterial
instances
of
noncompliance
reported in a separate communication to the
provider?3
[SAS 68, pars. 29 and 95 (AU 801.29 and .95)
GAS, Chap. 5, par. 8]

3 If there are no immaterial instances of noncompliance, the
auditor may so note in the report.
[SOP 92-9, par. 7.24]
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Yes

14. If the auditor issued a separate letter describ
ing immaterial instances of noncompliance, did
the compliance report include a reference to
that letter?
[SAS 68, pars. 29 and 30 (AU 801.29 and .30),
SOP 92-9, par. 7.16]
15. If the auditor became aware of illegal acts that
could result in criminal prosecution, have they
been communicated in a separate report to
management?
[SAS 68, par. 31 (AU 801.31); GAS Chap. 5, par.
5]
16. If the auditor became aware of illegal acts and
remains uncertain about whether they will mater
ially affect the financial statements, was the
report qualified or a disclaimer of opinion
issued?
[SOP 92-9, par. 7.18]
Other Matters

17. If performance audits are required by contract
ual obligations, were findings presented in
accordance with the guidance in The Yellow
Book??
[GAS, Ch. 2, pars. 6-10]
18. If the auditor is unable to follow an applicable
standard and is unable to withdraw from the en
gagement, did the auditor disclose in the scope
section of the report the fact that an appli
cable standard was not followed, the reasons
therefor, and the known effect of not following
the standard on the results of the audit?
[GAS, Ch. 3, par. 27]

19. Does the auditor's report disclose the status of
known but uncorrected significant or material
findings and recommendations from prior audits
that could have an effect on the current audit
objective?
[SAS 68, par. 20, footnote 10 (AU 801.20); GAS,
Ch. 3, par. 41, SOP 92-9, par. 7.41]
20. Does the auditor's report disclose in the scope
section of the report audit scope impairments
and the known effect they have on the results of
the audit?
[GAS, Ch. 3, par. 42]
21. Did the auditor consider the impact on his or
her report of the effects of noncompliance
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No

N/A

Yes

findings from other simultaneous audits that may
result in claims for refunds?
[SOP 92-9, par. 7.43; See also SFAS 5 (AC C59)]
22. Do the reports on the schedule of federal
awards,
compliance,
and
internal
control
structure carry the same date as the report on
the basic financial statements?
[SOP 92-9, par. 7.27]
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No

N/A

Yes

Part II - REPORTS
CIRCULAR A-133
1.

ON AUDITS

N/A

PERFORMED UNDER OMB

If the provider is subject to the requirements
of Circular A-133, are the following additional
reports issued?
a.

A report on a supplementary schedule of the
provider's federal awards?4

b.

A report on the internal control policies
and procedures used to administer federal
awards?

c.

A report on compliance with specific laws
and regulations that may have a direct and
material effect on each major program.

d.

A report on compliance with certain laws and
regulations applicable to nonmajor pro
grams.5

A
report
on
compliance
requirements.6
[SOP 92-9, par. 7.19]

e.

2

No

with

general

Does each auditor's report in step No. 1 contain
a statement that the audit was conducted in
accordance with generally accepted auditing
standards; Government Auditing Standards, issued
by the Comptroller General of the United States;
and Office of Management and Budget
(OMB)
Circular A-133?
[SOP 92-9, Appendix D, Exhibits D-8 through
D-18]

4 Under Circular A-133, a recipient or subrecipient of an award
is required to prepare a schedule of federal awards.
A sample
schedule is presented in the Illustrative Financial Statements
section of these checklists.
[Attachment to Circular A-133, par.
15(c)(1), SOP 92-9, pars. 4.7 and 7.20]

5
Under the Yellow Book, a report on the internal control
structure is required in all audits even if no reportable
conditions were noted.
[SAS 68, par. 33 (AU 801.33)]
6 A report on compliance with general requirements is required
regardless of whether there are any major programs.
[SOP 92-9,
par. 7.25]
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Yes

3.

Does the auditor's report
schedule of federal awards:
a.

on

the

provider's

Identify major programs?

b.
Show total expenditures for each program?
[A-133, item 15c(1)]
Report on Internal Control Structure
4.

Does the report on internal control structure
include:

a.

A description of the scope of the auditor's
work to test the internal control structure
policies and procedures?

A description of the provider's significant
control policies and procedures established
to provide reasonable assurance that it is
managing its federal awards in compliance
with applicable laws and regulations?
[SOP 92-9, par. 7.22]

b.

5.

If the auditor determines that tests of controls
are likely to be ineffective in preventing or
detecting noncompliance, is that matter dis
closed as a "reportable condition?"
[SOP 92-9, par. 7.23]

6.

If the auditor has limited his or her consid
eration of the internal control structure for
any reason, were the circumstances disclosed in
the report on the internal control structure?
[SOP 92-9, par. 7.23]

Report on Compliance with Specific Requirements
Related to Major Programs
7.

For audits of major programs, does the report on
compliance with specific requirements conform to
the standard report illustrated in SAS 68, par.
81 (AU 801.81)?

8.

If the auditor is disclaiming an opinion due to
a scope limitation:

a.

Were the reasons indicated, in a separate
paragraph, why the audit did not comply with
generally
accepted
auditing
standards,
Government
Auditing
Standards,
or
OMB
Circular A-133?

b.

Did the auditor state that the scope of the
audit was not sufficient to warrant the ex
pression of an opinion?
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No

N/A

Yes
Did the auditor disclose any reservations he
or she had regarding compliance with appli
cable laws and regulations?
[SAS 68, pars. 82 and 84 (AU 801.82 and .84)]

c.

9. If the auditor expresses a qualified or adverse
opinion due to material noncompliance on a major
federal program, did the auditor state the basis
for such an opinion in the report?
[SAS 68, par. 85 (AU 801.85)]

10.

If the auditing procedures disclosed instances
of noncompliance on major programs:

a.

c.

___

___

Did the resulting modification to the audi
tor's report on compliance consider factors
that include:
The number and types of instances of
noncompliance;

___

2.

Determinability of questioned costs; and

___

3.

Materiality of questioned costs.

___

1.

b.

___

If, after considering those factors, the
auditor concluded that the instances of
noncompliance had a material effect on a
federal program, was a qualified or adverse
opinion issued?
or
If after considering those factors, the
auditor was unable to determine if the
instance of noncompliance could have a
material effect on the program, does the
report state noncompliance occurred but the
effect on the programs presently cannot be
determined?

Is the effect of uncertainties associated
with federal programs on the basic financial
statements considered, and if necessary, was
the report modified?
[SOP 92-9; par. 7.24]

___

___

d.

11.

If the auditor was unable to examine appropriate
evidence to support the comply/noncomply decis
ion, was the report appropriately modified?
[SOP 92-9, par. 7.24]
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___

___

No

N/A

Yes

Report on Compliance with General Requirements
12.

Does the report on compliance with general re
quirements
conform to the
standard report
illustrated in SAS 68, par. 52 (AU 801.52)?

Report on Compliance Related to Nonmajor Programs

13.

For nonmajor programs, does the report on com
pliance
conform
to
the
standard
report
illustrated in SAS 68, par. 90 (AU 801.90)?

General

14.

Does the auditor's report on compliance with
laws and regulations include, for each federal
award:
a.

An identification of total amounts
tioned as a result of noncompliance?

Any corrective action recommended
auditor?
[SOP 92-9, pars. 7.30 and 7.32]

b.

ques
by

the

15.

Were any immaterial findings included either (1)
in a schedule of findings and costs, or (2) in a
separate communication to management?
[SOP 92-9, par. 7.30]

16.

If the audit is biennial, are both years within
the period covered?
[SOP 92-9, par. 2.47]
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No

N/A
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Property and equipment, net
(notes 6 and 7)

Noncurrent assets whose use
is limited

liabilities

Less assets whose use is limited
and that are required for current

limited

Total assets whose use is

Assets whose use is limited
(notes 5, 7, and 8)
By board for capital improvements
By agreements with third-party
payors for funded depreciation
Under malpractice funding
arrangement—held by trustee
Under indenture agreem entheld by trustee

Total current assets

Current assets
Cash and cash equivalents
Assets whose use is lim ited required for current liabilities
(notes 5 , 7, and 8)
Patient accounts receivable, net of
estimated uncollectibles of
$2,500,000 in 19X7 and $2,400,000
in 19X6 (note 15)
Estimated third-party payor
settlements—Medicare
(notes 3 and 15)
Supplies, at lower of cost
(first-in, first-out) or market
Other current assets
Due from donor-restricted funds

GENERAL FUNDS

_______________ Assets_______________

14,194,000

600,000
938,000
403,000
500,000

22,460,000

15,100,000

441,000

1,163,000
321,000

21,098,000

4,525,000

1,300,000

$

19X6

2,682,000
11,008,000

3,007,000
11,708,000

51,038,000

33,979,000

970,000

50,492,000

28,541,000

1,300,000

29,841,000

6,151,000

9,234,000

34,949,000

10,000,000

11,000,000

19X6

500,000
772,000
______ —

600,000
955,000
300,000

Fund balance

69,310,000

500,000

Capital lease obligations, excluding
current portion (note 7)

3,207,000

746,000

64,567,000

400,000

23,614,000

2,182,000

984,000

11,116,000

210,000
632,000

200,000
122,000

11,403,000

1,942,000

2,143,000

1,200,000
550,000
2,085,000
3,225,000

$

19X6

500,000
2,217,000
3,396,000

970,000

22,644,000

$

19X7

Long-term debt, excluding current
installments (note 7)

Estimated malpractice costs, net of
current portion (note 8)

Deferred third-party
reimbursement

Total current liabilities

Deferred third-party reimbursement
Advances from third-party payors
Current portion of estimated
malpractice costs (note 8)
Retainage and construction
accounts payable
Due to donor-restricted funds

Current liabilities
Current installments of long-term
debt (note 7)
Current portion of capital lease
obligations (note 7)
Accounts payable
Accrued expenses
Estimated third-party payor
settlements —Medicaid (note 2)

Liabilities and Fund Balances

3 1 , 19X7 and

970,000

3,103,000

______ —

$

19X7

December

Balance Sheets
(Disaggregated “ Layered ” Reporting *Approach)

SAMPLE HOSPITAL
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1,253,000

132,000
150,000
558,000

252,000

24,000

380,000

165,000

653,000

866,000
Fund balance

Due to general funds
Fund balance

Accounts payable
Deferred grant revenue
Due to general funds
Fund balance

Commitments and contingent
liabilities (notes 3 , 6 , 8, 12, and 13)

See accompanying notes to financial statements.

5,320,000
100,000
$ 6,073,000

$

$

______ —

$

321,000

1,368,000

$

1,719,000

3,856,000
150,000
$ 5,259,000

$

$

$

$

378,000

455,000
535,000

$

728,000
613,000

378,000

576,000
1,370,000
$102,863,000

917,000
1,695,000
$107,810,000

$

35,000
759,000

85,000
693,000

$

$

6,073,000

6,073,000

5,259,000

$

___________

5,259,000

$

___________

$

$

866,000

345,000
521,000

1,368,000

___________

$

$

255,000
1,041,000

—

72,000

558,000

558,000

—

1,719,000

$

___________

$

$

1,422,000

—

205,000
92,000

$102,863,000

$107,810,000

$

___________

____________

* The aggregated and disaggregated "layered" balance sheet reporting approaches by hospitals are presented for illustrative purposes. The aggregated approach
is presented on pages 64 and 65.

Endowment funds
Cash
Investments, net of $175,000
valuation allowance in 19X7,
market value $3,798,000 in 19X7
and $5,013,000 in 19X6 (note 9)
Due from general funds

Plant replacement and expansion
funds
Cash
Investments, at cost that
approximates market
Pledges receivable, net of estimated
uncollectibles of $60,000 in 19X7
and $120,000 in 19X6
Due from general funds

Cash
Investments, at cost that
approximates market
Grants receivable

DONOR-RESTRICTED FUNDS
Specific-purpose funds

Other assets
Prepaid pension cost (note 12)
Deferred financing costs
Investment in affiliated company
(note 4)
Total other assets
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Current assets
Cash and cash equivalents
Assets whose use is lim ited required for current liabilities
(notes 5 , 7 and 8)
Patient accounts receivable, net of
estimated uncollectibles of
$2,500,000 in 19X7 and $2,400,000
in 19X6 (note 15)
Estimated third-party payor
settlements—Medicare
(notes 3 and 15)
Supplies, at lower of cost
(first-in, first-out) or market
Other current assets
Total current assets
Assets whose use is limited or
restricted (notes 5, 7, 8 and 9)
By board for capital improvements
By agreements with third-party
payors for funded depreciation
Under malpractice funding
arrangement—held by trustee
Under indenture agreem entheld by trustee
By donors or grantors for specific
purposes
By donors for permanent
endowment funds

_______________Assets_______________

$

600,000
938,000
403,000
22,532,000

10,000,000

6,151,000
2,682,000
11,008,000

1,634,000

6,073,000

441,000

1,163,000
321,000
21,095,000

11,000,000

9,234,000
3,007,000
11,708,000

2,277,000

5,259,000

1,372,000

5,025,000

14,194,000

$

19X6

19X6

955,000

600,000

38,497,000

500,000

Capital lease obligations, excluding
current installments (note 7)
Total liabilities

22,644,000

3,207,000

Estimated malpractice costs, net of
current portion (note 8)

Long-term debt, excluding current
installments (note 7)

984,000

746,000
Deferred third-party reimbursement

38,368,000

400,000

23,614,000

2,182,000

11,188,000

______ —

772,000

500,000

1,942,000
210,000
632,000

2,143,000
200,000
122,000

1,200,000
550,000
2,157,000
3,225,000

$

19X6

500,000
2,422,000
3,396,000

970,000

______ 92,000

$

19X7

11,400,000

Current liabilities
Current installments of long-term
debt (note 7)
Current portion of capital lease
obligations (note 7)
Accounts payable
Accrued expenses
Estimated third-party payor
settlements —Medicaid (note 2)
Deferred third-party reimbursement
Advances from third-party payors
Current portion of estimated
malpractice costs (note 8)
Retainage and construction
accounts payable
Advances and deferred revenue
Total current liabilities

Liabilities and Fund Balances

3 1 , 19X7 and

15,100,000

1,267,000

2,803,000

19X7

December

Balance Sheets
(Aggregated Approach)
*

SAMPLE HOSPITAL
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576,000

1,370,000

$110,570,000

917,000

1,695,000

$115,046,000

35,000
759,000

50,492,000

51,038,000
85,000
693,000

36,176,000

1,372,000

37,548,000

41,218,000

1,267,000

42,485,000

Commitments and contingent
liabilities (notes 3, 6, 8, 12 and 13)

$115,046,000

$110,570,000

72,202,000

6,073,000

5,259,000

Permanently restricted by donors

76,549,000

1,562,000

1,980,000

Total net assets

64,567,000

69,310,000

Net assets
Unrestricted
Temporarily restricted by donors/
grantors

* The aggregated and disaggregated "layered" balance sheet reporting approaches by hospitals are presented for illustrative purposes. The disaggregated
"layered" reporting approach is presented on pages 86 and 87.

Total other assets

Investment in affiliated company
(note 4)

Other assets
Prepaid pension cost (note 12)
Deferred financing costs

Noncurrent assets whose use
is limited or restricted
Property and equipment, net
(notes 5 and 6)

Less assets whose use is limited
and that are required for current
liabilities

limited or restricted

Total assets whose use is

SAMPLE HOSPITAL

Statements of Revenue and Expenses of General Funds
Years Ended December 31,19X7 and 19X6

Net patient service revenue (notes 3, 7 and 15)

Other revenue
Total revenue

Expenses (notes 7, 8, 12, and 13)
Professional care of patients
Dietary services
General services
Administrative services
Employee health and welfare
Medical malpractice costs
Depreciation and amortization of property and equipment
Interest
Provision for bad debts
Total expenses

Income from operations

Nonoperating gains (losses)
Unrestricted gifts and bequests (note 10)
Loss on investment in affiliated company (note 4)
Income on investments of endowment funds
Income on investments whose use is limited
By board for capital improvements
By agreements with third-party payors for funded depreciation
Under indenture agreement
Other investment income
Nonoperating gains, net
Revenue and gains in excess of expenses and losses

See accompanying notes to financial statements.
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19X7

19X6

$92,656,000

$88,942,000

6,010,000

5,380,000

98,666,000

94,322,000

53,016,000
4,407,000
10,888,000
11,075,000
10,000,000
1,125,000
4,782,000
1,752,000
1,010,000

48,342,000
4,087,000
9,973,000
10,145,000
9,335,000
200,000
4,280,000
1,825,000
1,103,000

98,055,000

89,290,000

611,000

5,032,000

822,000
(37,000)
750,000

926,000
(16,000)
650,000

1,120,000
850,000
100,000
284,000

1,050,000
675,000
90,000
226,000

3,889,000

3,601,000

$ 4,500,000

$ 8,633,000

89
_____ —

$69,310,000

Balances at end of year

60,000
$558,000

550,000

$1,422,000

550,000

60,000

$5,259,000

814,000

175,000

-

639,000

-

-

$6,073,000

$64,567,000

1,000,000

-

1,000,000

50,000
$521,000

500,000

$1,041,000

500,000

50,000

70,000

8,888,000

290,000
15,000
20,000
(255,000)

608,000

558,000
50,000

$501,000

$ 933,000

255,000

8,633,000

$56,679,000

General
Funds

See accompanying notes to financial statements.

—

—
—

—

97,000

931,000

4,743,000

220,000
20,000
100,000

$521,000

(243,000)

869,000
62,000

$1,041,000

243,000

—
—
—

4,500,000

$64,567,000

Deductions
Provision for uncollectible pledges
Capital contribution to Sample
Health System (note 11)
Net realized loss on sale of investments
Unrealized loss on marketable equity
securities (note 9)
Transfer to other revenue

Additions
Revenue and gains in excess of
expenses and losses
Gifts, grants, and bequests
(notes 10 and 11)
Investment income
Net realized gain on sale of investments
Transfer to finance property and
equipment additions

Balances at beginning of year

General
Funds

Plant
Replacement
and Expan 
sion Funds

$6,073,000

100,000

100,000

$5,973,000

Endowment
Funds

_______ Donor-Restricted Funds_______

SpecificPurpose
Funds

_______________________ 19X6_______________________

19X7_______________________

Donor-Restricted Funds_______
Plant
Specific- Replacement
and Expan  Endowment
Purpose
Funds
sion Funds
Funds

Statements of Changes in Fund Balances
Years Ended December 3 1 , 19X7 and 19X6

SAMPLE HOSPITAL

SAMPLE HOSPITAL
Statements of Cash Flows of General Funds (Direct Method)*
Years Ended December 31,19X7 and 19X6

Cash flows from operating activities and gains and losses
Cash received from patients and third-party payors
Cash paid to employees and suppliers
Other receipts from operations
Receipts from unrestricted gifts and bequests
Interest and dividends received
Interest paid (net of amount capitalized)

Net cash provided by operating activities and gains and losses
Cash flows from investing activities
Purchase of property and equipment
Transfer from donor-restricted fund for purchase of property
and equipment
Investment in affiliated company
Transfer to Sample Health System
Cash invested in assets whose use is limited

Net cash used by investing activities

Cash flows from financing activities
Increase in retainage and construction accounts payable
Repayment of long-term debt
Payments from donor-restricted funds related to temporary loans
Payments on capital lease obligations
Temporary loans from (to) donor-restricted funds
Net cash used by financing activities
Net increase (decrease) in cash and cash equivalents

Cash and cash equivalents at beginning of year

Cash and cash equivalents at end of year

19X7

19X6

$ 90,342,000
(89,214,000)
6,042,000
1,122,000
2,510,000
(1,780,000)

$ 85,619,000
(81,510,000)
5,563,000
905,000
2,330,000
(1,856,000)

9,022,000

11,051,000

(4,728,000)

(5,012,000)

243,000
(394,000)

(4,798,000)

255,000
(425,000)
(1,000,000)
(855,000)

(9,677,000)

(7,037,000)

183,000
(1,200,000)
500,000
(550,000)
300,000

175,000
(1,630,000)

(767,000)

(2,248,000)

(600,000)
(193,000)

(1,422,000)

1,766,000

4,525,000

2,759,000

$ 3,103,000

$ 4,525,000

See accompanying notes to financial statements.

* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes.
The indirect method is presented on page 94.
90

Reconciliation of Revenue and Gains in Excess of Expenses and Losses
to Net Cash Provided by Operating Activities and Gains and Losses

Revenue and gains in excess of expenses and losses
Adjustments to reconcile revenue and gains in excess of expenses
and losses to net cash provided by operating activities and gains and losses
Depreciation and amortization of property and equipment
Provision for bad debts
Amortization of deferred financing costs
Loss on investment in affiliated company
Noncash gifts and bequests
Decrease in amounts due to third-party payors
Increase in liability for estimated malpractice costs
Increase in patient accounts receivable
Increase in supplies and other current assets
Increase in accounts payable and accrued expenses
Increase in interest earned but not received on assets whose use is limited
Net cash provided by operating activities and gains and losses

$4,500,000

4,782,000
1,010,000
66,000
53,000
—
(398,000)
1,125,000
(1,916,000)
(193,000)
303,000
(310,000)

$ 9,022,000

Supplemental Disclosures of Cash Flow Information

Sample Hospital entered into capital lease obligations of $600,000 for new equipment in 19X7.

See accompanying notes to financial statements.
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$ 8,633,000

4,280,000
1,103,000
45,000
—
(175,000)
(77,000)
200,000
(3,141,000)
(118,000)
301,000
—
$11,051,000

SAMPLE HOSPITAL

Statements of Cash Flows of General Funds (Indirect Method)*
Years Ended December 31,19X7 and 19X6

Cash flows from operating activities and gains and losses
Revenue and gains in excess of expenses and losses
Adjustments to reconcile revenue and gains in excess of expenses and
losses to net cash provided by operating activities and gains and losses
Depreciation and amortization of property and equipment
Provision for bad debts
Amortization of deferred financing costs
Loss on investment in affiliated company
Noncash gifts and bequests
Decrease in net amounts due to third-party payors
Increase in liability for estimated malpractice costs
Increase in patient accounts receivable
Increase in supplies and other current assets
Increase in accounts payable and accrued expenses
Increase in interest earned but not received on assets whose use is limited
Net cash provided by operating activities and gains and losses

Cash flows from investing activities
Purchase of property and equipment
Transfer from donor-restricted fund for purchase of property
and equipment
Investment in affiliated company
Transfer to Sample Health System
Cash invested in assets whose use is limited
Net cash used by investing activities

Cash flows from financing activities
Increase in retainage and construction accounts payable
Repayment of long-term debt
Payments from donor-restricted funds related to temporary loans
Payments on capital lease obligation
Temporary loans from (to) donor-restricted funds
Net cash used by financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of year

Cash and cash equivalents at end of year

19X7

19X6

$ 4,500,000

$ 8,633,000

4,782,000
1,010,000
66,000
53,000
—
(398,000)
1,125,000
(1,916,000)
(193,000)
303,000
(310,000)

4,280,000
1,103,000
45,000
—
(175,000)
(77,000)
200,000
(3,141,000)
(118,000)
301,000
—

9,022,000

11,051,000

(4,728,000)

(5,012,000)

243,000
(394,000)
—
(4,798,000)

255,000
(425,000)
(1,000,000)
(855,000)

(9,677,000)

(7,037,000)

183,000
(1,200,000)
500,000
(550,000)
300,000

175,000
(1,630,000)
—
(600,000)
(193,000)

(767,000)

(2,248,000)

(1,422,000)

1,766,000

4,525,000

2,759,000

$ 3,103,000

$ 4,525,000

Supplemental Disclosures of Cash Flow Information
Sample Hospital entered into capital lease obligations of $600,000 for new equipment in 19X7.
Cash paid for interest (net of amount capitalized) in 19X7 and 19X6 was $1,780,000 and $1,856,000, respectively.

See accompanying notes to financial statements.
* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes.
The direct method is presented on pages 92 and 93.
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SAMPLE HOSPITAL
Notes to Financial Statements
December 31,19X7 and 19X6
1. Summary of Significant Accounting Policies
Organization
Sample Hospital (Hospital) is a not-for-profit acute care hospital. Effective June 30,19X6, under a plan of reorganiza
tion, Sample Health System was formed as the parent holding company of the Hospital. In its capacity as sole
member of the Hospital, Sample Health System has the right to appoint Hospital trustees, approve major Hospital
expenditures, and approve long-term Hospital borrowings.
Charity care
The Hospital provides care to patients who meet certain criteria under its charity care policy without charge or at
amounts less than its established rates. Because the Hospital does not pursue collection of amounts determined to
qualify as charity care, they are not reported as revenue.
Income taxes
The Hospital is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and is
exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.

Net patient service revenue
Net patient service revenue is reported at the estimated net realizable amounts from patients, third-party payors,
and others for services rendered, including estimated retroactive adjustments under reimbursement agreements
with third-party payors. Retroactive adjustments are accrued on an estimated basis in the period the related services
are rendered and adjusted in future periods as final settlements are determined.

Investments and investment income
Donated investments are reported at fair value at the date of receipt, which is then treated as cost. Marketable equity
securities included in investment portfolios are carried at the lower of aggregate cost (determined on an average-cost
basis) or market at the balance sheet date. Other marketable securities are stated at cost, adjusted for impairments
in value that are deemed to be other than temporary. Sample Hospital's investment in Affiliated Company is
reported on the equity method of accounting that approximates Sample Hospital's equity in the underlying net
assets of Affiliated Company.
Investment income on proceeds of borrowings that are held by a trustee, to the extent not capitalized, and invest
ment income on assets deposited in the malpractice trust are reported as other revenue. Investment income from
all other general fund investments and investment income of endowment funds are reported as nonoperating
gains. Investment income and gains (losses) on investments of donor-restricted funds are added to (deducted from)
the appropriate restricted fund balance.
Pledges
Pledges, less an allowance for uncollectible amounts, are recorded as receivables in the year made. Unrestricted
pledges are reported in the statement of revenue and expenses of general funds; restricted pledges are reported as
additions to the appropriate restricted fund balance.
Statement of revenue and expenses of general funds
For purposes of display, transactions deemed by management to be ongoing, major, or central to the provision of
health care services are reported as revenues and expenses. Peripheral or incidental transactions are reported as
gains and losses.

Costs of borrowing
Interest cost incurred on borrowed funds during the period of construction of capital assets is capitalized as a
component of the cost of acquiring those assets.
Deferred financing costs are amortized over the period the obligation is outstanding using the interest method.
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Amortization of deferred financing costs is capitalized during the period of construction of capital assets.
Donor-restricted funds
Donor-restricted funds are used to differentiate resources, the use of which is restricted by donors or grantors, from
resources of general funds on which donors or grantors place no restriction or that arise as a result of the operations
of the Hospital for its stated purposes. Restricted gifts and other restricted resources are recorded as additions to
the appropriate restricted fund.

Resources restricted by donors for plant replacement and expansion are added to the general fund balance to the
extent expended within the period.
Resources restricted by donors or grantors for specific operating purposes are reported in other operating revenue
to the extent used within the period.

Assets whose use is limited
Assets whose use is limited include assets set aside by the Board of Trustees for future capital improvements, over
which the Board retains control and may at its discretion subsequently use for other purposes; assets set aside in
accordance with agreements with third-party payors; and assets held by trustees under indenture agreements and
self-insurance trust arrangements.
Property and equipment
Property and equipment acquisitions are recorded at cost. Property and equipment donated for hospital operations
are recorded as additions to the donor-restricted plant replacement and expansion funds at fair value at the date of
receipt and as transfers to the general fund balance when the assets are placed in service.
Depreciation is provided over the estimated useful life of each class of depreciable asset and is computed on the
straight-line method. Equipment under capital leases is amortized on the straight-line method over the shorter
period of the lease term or the estimated useful life of the equipment. Such amortization is included in depreciation
and amortization in the financial statements.

An accelerated method for depreciating certain operating equipment acquired before 1970 has been elected for
third-party reimbursement purposes. Third-party reimbursement is deferred to the extent of the effect of the differ
ence between accelerated depreciation used for reimbursement reporting and straight-line depreciation used for
financial reporting.
Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three months
or less, excluding amounts whose use is limited by board designation or other arrangements under trust agree
ments or with third-party payors.
Estimated malpractice costs
The provision for estimated self-insured medical malpractice claims includes estimates of the ultimate costs for both
reported claims and claims incurred but not reported.

2. Charity Care
The Hospital maintains records to identify and monitor the level of charity care it provides. These records include
the amount of charges foregone for services and supplies furnished under its charity care policy, the estimated cost
of those services and supplies, and equivalent service statistics. The following information measures the level of
charity care provided during the years ended December 31,19X7 and 19X6.

Charges foregone, based on established rates
Estimated costs and expenses incurred to provide charity care
Equivalent percentage of charity care patients to all patients served
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19X7

19X6

$6,000,000
5,600,000
5.7%

$5,700,000
5,000,000
5.6%

3. Net Patient Service Revenue
The Hospital has agreements with third-party payors that provide for payments to the Hospital at amounts different
from its established rates. A summary of the payment arrangements with major third-party payors follows.

• Medicare. Inpatient acute care services rendered to Medicare program beneficiaries are paid at prospectively
determined rates per discharge. These rates vary according to a patient classification system that is based on
clinical, diagnostic, and other factors. Inpatient nonacute services, certain outpatient services, and defined
capital and medical education costs related to Medicare beneficiaries are paid based upon a cost reimburse
ment methodology. The Hospital is reimbursed for cost reimbursable items at a tentative rate with final
settlement determined after submission of annual cost reports by the Hospital and audits thereof by the
Medicare fiscal intermediary. The Hospital's classification of patients under the Medicare program and the
appropriateness of their admission are subject to an independent review by a peer review organization under
contract with the Hospital. The Hospital's Medicare cost reports have been audited by the Medicare fiscal
intermediary through December 31,19X6.
• Medicaid. Inpatient and outpatient services rendered to Medicaid program beneficiaries are reimbursed
under a cost reimbursement methodology. The Hospital is reimbursed at a tentative rate with final settlement
determined after submission of annual cost reports by the Hospital and audits thereof by the Medicaid fiscal
intermediary. The Hospital's Medicaid cost reports have been audited by the Medicaid fiscal intermediary
through December 31, 19X6.
• Blue Cross. Inpatient services rendered to Blue Cross subscribers are reimbursed at prospectively deter
mined rates per day of hospitalization. The prospectively determined per diem rates are not subject to
retroactive adjustment.
The Hospital has also entered into payment agreements with certain commercial insurance carriers, health main
tenance organizations, and preferred provider organizations. The basis for payment to the Hospital under these
agreements includes prospectively determined rates per discharge, discounts from established charges, and
prospectively determined daily rates.

4. Investment in Affiliated Company
In 19X2, the Hospital entered into an agreement with two unrelated hospitals to establish and operate an ambula
tory care center, Affiliated Company (Center). In accordance with this agreement, each hospital invested $970,000
for a 33⅓ percent equity interest in the common stock of the Center. The investment was made in installments
during the years 19X5 through 19X7, and in May 19X7 the Center began operations. The investment is recorded on
the equity method.
Summarized financial information from the unaudited financial statements of the Center follows.

Current assets
Noncurrent assets
Current liabilities
Noncurrent liabilities
Shareholders' equity

December 31,19X7

December 31,19X6

$1,779,000
4,052,000
1,566,000
1,514,000
2,751,000

$1,835,000
4,007,000
1,325,000
2,789,000
1,728,000

YearEnded
December 31,19X6
December 31,19X7
Revenue
Net loss

$3,220,000
(111,000)
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$2,899,000
(48,000)

5.

Assets Whose Use Is Limited

Assets whose use is limited that are required for obligations classified as current liabilities are reported in current
assets. The composition of assets whose use is limited at December 31,19X7 and 19X6, is set forth in the following
table. Investments are stated at cost that approximates market.
19X7

19X6

By board for capital improvements
Cash and short-term investments

$11,000,000

$10,000,000

By agreements with third-party payors for funded depreciation
Cash and short-term investments
U.S. Treasury obligations
Interest receivable

$ 8,503,000
316,000
415,000

$ 5,712,000
316,000
123,000

$ 9,234,000

$ 6,151,000

$ 1,058,000
1,949,000

$

$ 3,007,000

$ 2,682,000

$ 592,000
11,024,000
92,000

$ 1,260,000
9,674,000
74,000

$11,708,000

$11,008,000

19X7

19X6

$ 3,000,000
472,000
46,852,000
29,190,000
2,851,000

$ 3,000,000
472,000
46,636,000
26,260,000
2,752,000

Under malpractice funding arrangement—held by trustee
Cash and short-term investments
U.S. Treasury obligations

Under indenture agreement—held by trustee
Cash and short-term investments
U.S. Treasury obligations
Interest receivable

857,000
1,825,000

6. Property and Equipment

A summary of property and equipment at December 31,19X7 and 19X6, follows.

Land
Land improvements
Buildings and improvements
Equipment
Equipment under capital leases

Less accumulated depreciation and amortization

Construction in progress
Property and equipment, net

82,365,000

79,120,000

34,928,000

30,661,000

47,437,000
3,601,000
$51,038,000

48,459,000
2,033,000
$50,492,000

Construction contracts of approximately $7,885,000 exist for the remodeling of Hospital facilities. At December 31,
19X7, the remaining commitment on these contracts approximated $4,625,000.
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7. Long-Term Debt and Capital Leases
A summary of long-term debt and capital leases at December 31,1987 and 19X6, follows.

9.25% Revenue Notes, due November 1,19XX, collateralized by a pledge
of the Hospital's gross receipts
9.25% mortgage loan, due January 19XX, collateralized by a mortgage
on property and equipment with a depreciated cost of $1,800,000 at
December 31,19X7
9.75% note payable, due March 19XX, unsecured
Total long-term debt
Less current instalments of long-term debt

Long-term debt excluding current installments

Capital lease obligations, at varying rates of imputed interest from 9.8%
to 12.3%, on leased equipment with an amortized cost of $1,500,000
at December 31,19X7
Less current portion of capital lease obligations

19X7

19X6

$21,479,000

$22,016,000

2,010,000
125,000

2,127,000
671,000

23,614,000
970,000

24,814,000
1,200,000

$22,644,000

$23,614,000

$ 1,000,000
500,000

$

$ 500,000

Capital lease obligations, excluding current portion

950,000
550,000

$ 400,000

Under the terms of the Revenue Note Indenture, the Hospital is required to maintain certain deposits with a trustee.
Such deposits are included with assets whose use is limited in the financial statements. The Revenue Note Inden
ture also places limits on the incurrence of additional borrowings and requires that the Hospital satisfy certain
measures of financial performance as long as the notes are outstanding.
Scheduled principal repayments on long-term debt and payments on capital lease obligations for the next five years
are as follows:
Obligations
Under Capital
Long-Term
Leases
Debt

19X8
19X9
19Y0
19Y1
19Y2

$ 970,000
912,000
983,000
1,060,000
1,143,000

$ 500,000
260,000
260,000
95,000
—

$5,068,000

1,115,000

Less amount representing interest on
obligations under capital leases

115,000
$1,000,000

A summary of interest cost and investment income on borrowed funds held by the trustee under the Revenue Note
Indenture during 19X7 and 19X6 follows.
19X7
19X6
Interst cost
Capitalized
Charged to operations

Investment income
Capitalized
Credited to other revenue
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$ 740,000
1,752,000
$2,492,000

$ 740,000
1,825,000
$2,565,000

$ 505,000
330,000
$ 835,000

$ 663,000
386,000
$1,049,000

8. Medical Malpractice Claims

The Hospital is uninsured with respect to medical malpractice risks. Losses from asserted claims and from
unasserted claims identified under the Hospital's incident reporting system are accrued based on estimates that
incorporate the Hospital's past experience, as well as other considerations including the nature of each claim or
incident and relevant trend factors. Accrued malpractice losses have been discounted at rates ranging from 7 percent
to 9 percent. No accrual for possible losses attributable to incidents that may have occurred but that have not been
identified under the incident reporting system has been made because the amount is not reasonably estimable.
The Hospital has established an irrevocable trust fund for the payment of medical malpractice claim settlements.
Professional insurance consultants have been retained to assist the Hospital with determining amounts to be
deposited in the trust fund.
9. Endowment Funds—Investments

Donor-restricted endowment fund investment portfolios include marketable equity securities that are carried at
the lower of cost or market. Marketable equity securities of endowment funds at December 31,19X7 and 19X6, are
summarized as follows:
Gross
Quoted
Gross
Unrealized
Unrealized
Market
Gains
Losses
Cost
Value
19X7
19X6

$1,476,000
1,620,000

$1,301,000
1,832,000

$

8,000
228,000

$183,000
16,000

Realized gains on marketable equity securities of endowment funds amounted to $10,000 in 19X7 and $50,000
in 19X6.

10. Assets Held in Trust
The Hospital is an income beneficiary of the Thomas A. Smith Trust. Because the assets of the trust are not
controlled by the Hospital, they are not included in the Hospital's financial statements. At December 31,19X7, the
market value of the assets totaled approximately $2,652,000. Distributions of income are made at the discretion of
the trustees. Income distributed to the Hospital by the trust is restricted for construction or equipment additions
and amounted to $150,000 in 19X7 and $140,000 in 19X6.

11. Related Party Transactions
Because of the existence of common trustees and other factors, the Hospital and Sample Health Foundation (Foun
dation) are related parties. The Foundation is authorized by the Hospital to solicit contributions on its behalf. In its
general appeal for contributions to support the community's providers of health care services, the Foundation also
solicits contributions for certain other health care institutions. In the absence of donor restrictions, the Foundation
has discretionary control over the amounts, timing, and use of its distributions.
Contributions made by the Foundation to the Hospital during the years ended December 31, 19X7 and 19X6, are
reported in the Hospital's financial statements as follows:
19X7
19X6

Unrestricted gifts and bequests
Restricted contributions for—
Specific purposes
Plant replacement and expansion

$375,000

$525,000

300,000
70,000

200,000
85,000

In addition, the Hospital made a capital contribution of $1,000,000 to Sample Health System during 19X6.
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12. Pension Plan
The Hospital has a defined benefit pension plan covering substantially all of its employees. The plan benefits are
based on years of service and employee compensation during the last five years of covered employment. The Hospital
makes annual contributions to the plan equal to the amounts of net periodic pension cost. Contributions are
intended to provide not only for benefits attributed to service to date but also for those expected to be earned in the
future.

The actuarially computed net periodic pension cost for 19X7 and 19X6 included the following components:

Service cost-benefits earned during the
period
Interest cost on projected benefit obli
gation
Actual return on plan assets
Net amortization and deferral

19X7

19X6

$905,000

$ 770,000

$ 725,000

Net periodic pension cost

650,000
(800,000)
80,000

700,000
(950,000)
70,000

$ 700,000

Assumptions used in the accounting for net periodic pension cost were as follows:

As of December 31
19X7
19X6
Discount rates
Rates of increase in compensation levels
Expected long-term rate of return on assets

7.0%
6.0
8.0

7.0%
6.0
8.0

The following table sets forth the plan's funded status and amounts recognized in the Hospital's financial state
ments at December 31, 19X7 and 19X6.
19X7

19X6

$ 8,020,000
1,900,000

$6,800,000
1,930,000

Accumulated benefit obligation

9,920,000

8,730,000

Effect of projected future compensation levels

1,000,000

980,000

10,920,000

9,710,000

11,050,000

9,800,000

Actuarial present value of benefit obligations
Vested benefit obligation
Nonvested benefit obligation

Projected benefit obligation
Plan assets at fair value (primarily listed stocks and U.S. bonds)

Plan assets in excess of projected benefit obligation
Unrecognized net gain from past experience different from that assumed
Prior service cost not yet recognized in net periodic pension cost
Unrecognized net asset at January 1,19X6, being recognized over 15 years

Prepaid pension cost, included in other assets in the balance sheet
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$

130,000

90,000

(30,000)
50,000
(65,000)

(40,000)
55,000
(70,000)

85,000

$

35,000

13. Commitments
Leases that do not meet the criteria for capitalization are classified as operating leases with related rentals charged
to operations as incurred.

The following is a schedule by year of future minimum lease payments under operating leases as of December 31,
19X7, that have initial or remaining lease terms in excess of one year.
Year Ending
December 31

Minimum Lease
Payments

19X8
19X9
19Y0
19Y1
19Y2
Total minimum lease payments

$ 517,000
506,000
459,000
375,000
343,000
$2,200,000

Total rental expense in 19X7 and 19X6 for all operating leases was approximately $859,000 and $770,000, respectively.

14. Subsequent Event
On February 9, 19X8, the Hospital signed a contract in the amount of $1,050,000 for the purchase of certain real
estate.

15. Concentrations of Credit Risk
The Hospital is located in Feeling, Illinois. The Hospital grants credit without collateral to its patients, most of whom
are local residents and are insured under third-party payor agreements. Revenues from patients and third-party
payors were as follows:

Medicare and Medicaid
Blue Cross
Other third-party payors
(none over 10%)
Patients

100

19X7

19X6

20%
20

19%
19

27
33
100%

26
36
100%
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Less accumulated depreciation
Property and equipment, net
Other assets
Note receivable
Bond issuance cost, net of accumulated
amortization of $38,000 in 19X2 and
$32,000 in 19X1
Land held for investment
Total other assets
Total assets

Current assets
Cash and cash equivalents
Investments, at cost that
approximates market
Assets whose use is limited—required
for current liabilities
Patient accounts receivable less allowance
for doubtful accounts: 19X2—$6,700;
19X1—$5,300
Estimated third-party payor settlements
Interest receivable
Supplies
Prepaid expenses
Total current assets
Assets whose use is limited
Under indenture agreement—held by
trustee
By board for capital improvements
Total assets whose use is limited
Less assets whose use is limited and that
are required for current liabilities
Noncurrent assets whose use is
limited
Property and equipment
Land
Land improvements
Buildings
Furniture, fixtures, and equipment

_________________ Assets_________________

152,000
62,000

57,000
2,000
452,000

153,000
47,000
200,000

50,000
150,000

205,000
32,000
1,399,000
189,000
1,825,000
141,000
1,684,000

72,000

48,000
7,000
127,000
$2,413,000

162,000
71,000
7,000
59,000
3,000
597,000

176,000
47,000
223,000

50,000
173,000

205,000
37,000
1,399,000
228,000
1,869,000
210,000
1,659,000
81,000

42,000
27,000
150,000
$2,579,000

equity

Total liabilities and shareholders'

Shareholders' equity
Common stock, $20 par value; authorized
5,000 shares; issued and outstanding
3,500 shares
Retained earnings
Total shareholders' equity

Long-term debt, less current maturities

Deferred income tax liability

Current liabilities
Current maturities of long-term debt
Accounts payable
Accrued expenses
Deposits from patients
Income taxes payable
Total current liabilities

Liabilities and Shareholders' Equity

19X1

See accompanying notes to financial statements.

—

50,000

50,000

$ 129,000
—

95,000

19X1

3 1 , 19X2 and

150,000

$

19X2

December

Balance Sheets

SAMPLE NURSING HOME, INC.

$2,413,000

70,000
229,000
299,000

1,750,000

14,000

50,000
52,000
188,000
45,000
15,000
350,000

_________

$

$2,579,000

70,000
376,000
446,000

1,700,000

6,000

50,000
78,000
175,000
50,000
74,000
427,000

19X1

_________

$

19X2

SAMPLE NURSING HOME, INC.
Statements of Income and Retained Earnings
Years Ended December 31,19X2 and 19X1

19X2

19X1

$ 2,163,000

$ 1,949,000

67,000

22,000

Total revenue

2,230,000

1,971,000

Expenses
Nursing services
Dietary services
General services
Administrative services
Interest
Provision for bad debts
Depreciation

1,083,000
228,000
212,000
173,000
164,000
92,000
69,000

1,010,000
225,000
212,000
147,000
172,000
83,000
57,000

Total expenses

2,021,000

1,906,000

209,000

65,000

Net patient service revenue

Other revenue

Income from operations
Nonoperating gains—interest and dividends

Income before provision for income taxes
Provision for income taxes
Net income

Retained earnings at beginning of year

18,000

7,000

227,000

72,000

80,000

29,000

147,000

43,000

186,000

229,000

Retained earnings at end of year

$

See accompanying notes to financial statements.
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376,000

$

229,000

SAMPLE NURSING HOME, INC.
Statements of Cash Flows
Years Ended December 31,19X2 and 19X1

Cash flows from operating activities and gains
Cash received from residents and third-party payors
Cash received from others
Cash paid to employees and suppliers
Interest and dividends received
Interest paid
Taxes paid
Deposits received from patients
Deposits refunded to patients

19X2

19X1

$ 2,048,000
67,000
(1,679,000)
10,000
(160,000)
(29,000)
35,000
(30,000)

$ 1,796,000
22,000
(1,495,000)
10,000
(170,000)
(30,000)
15,000
(20,000)

Net cash provided by operating activities and gains
Cash flows from investing activities
Purchase of land held for investment
Purchase of other investments
Proceeds from sale of property
Additions to property and equipment
Cash invested in assets whose use is limited
Increase in notes receivable
Net cash used in investing activities

Cash flows from financing activities
Repayment of long-term debt
Net cash used by financing activities

262,000

128,000

(20,000)
(150,000)
—
(44,000)
(23,000)
(9,000)

—
—
2,000
(79,000)
—
—

(246,000)

(77,000)

(50,000)

(50,000)

(50,000)

(50,000)

Net increase (decrease) in cash

(34,000)

Cash at beginning of year

129,000

Cash at end of year

$

95,000

1,000

128,000
$

129,000

Reconciliation of Net income to Net Cash Provided by Operating Activities and Gains
Net income
Adjustments to reconcile net income to net cash provided by
operating activities and gains
Depreciation
Provision for bad debts
Amortization
Loss on disposal of property
Increase (decrease) in deferred income tax liability
Net effect of changes in receivables, supplies, prepaid expenses,
accounts payable, accrued expenses, and deposits
Net cash provided by operating activities and gains

See accompanying notes to financial statements.
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$147,000

69,000
92,000
6,000
—
(8,000)
(44,000)
$262,000

$ 43,000

57,000
83,000
6,000
11,000
7,000

(79,000)

$128,000

SAMPLE NURSING HOME, INC.
Notes to Financial Statements
December 31,19X2 and 19X1

1. Summary of Significant Accounting Policies
Sample Nursing Home, Inc. (Company) operates a 128-bed nursing home in Abacus, New State. A summary of the
Company's significant accounting policies follows.
Income taxes
The provisions for income taxes are based on net income reported for financial reporting purposes. Deferred
income taxes arise from temporary differences between financial and income tax reporting of various items (prin
cipally depreciation). Tax credits are treated as a reduction of the provision for income taxes in the year in which the
credits arise.
Patient service revenue
Patient service revenue is reported at the estimated net realizable amounts from residents, third-party payors, and
others for service rendered.

Revenue under third-party payor agreements is subject to audit and retroactive adjustment. Provisions for esti
mated third-party payor settlements are provided in the period the related services are rendered. Differences
between the estimated amounts accrued and interim and final settlements are reported in operations in the year of
settlement.

Assets whose use is limited
Assets set aside by the board of directors for capital improvements and assets limited as to use under terms of a note
indenture are classified as assets whose use is limited.
Property and equipment
Property and equipment are recorded at cost. Depreciation is calculated on the straight-line method over the
estimated useful lives of depreciable assets.
Bond issuance costs
Costs incurred in issuing bonds are being amortized over the term of the bonds using the straight-line method.
Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three months
or less, excluding amounts whose use is limited by board designation or note indenture.

2. Assets Whose Use Is Limited

Assets whose use is limited under a note indenture agreement at December 31,19X2 and 19X1, are summarized as
follows:

U.S. Treasury obligations, at cost that approximates market

Cash
Accrued interest income

19X2

19X1

$150,000

$130,000

23,000
3,000

21,000
2,000

$176,000

$153,000

Assets set aside by the board of directors for capital improvements consists of certificates of deposit, at a cost that
approximates market.
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3. Long-Term Debt
Long-term debt at December 31, 19X2 and 19X1, was as follows:

9.5 percent notes payable to the City of Abacus, maturing $50,000
annually through November 1,19XX, with a final maturity of $1,000,000
on November 1, 20XX
Less current maturities

19X2

19X1

$1,750,000

$1,800,000

50,000

50,000

$1,700,000

$1,750,000

The notes are collateralized by a first-mortgage lien on all property and equipment of the Company and a security
interest in all of its receipts. The note indenture requires the maintenance of certain deposits with a trustee, which
are included in assets whose use is limited.
Future maturities of long-term debt as of December 31,19X2, follow.
19X3
19X4
19X5
19X6
19X7
Thereafter

5

Total

$1,750,000

50,000
50,000
50,000
50,000
50,000
1,500,000

4. Income Taxes
The provisions for income taxes on earnings were as follows:

Current
Federal
State
Total current

Deferred
Federal
State
Total deferred
Total provision for income taxes

19X2

19X1

$72,000
2,000

$15,000

74,000

15,000

6,000
—

13,000
1,000

6,000

14,000

$80,000

$29,000

A reconciliation between the "statutory" federal income tax rate and the effective rate in the statements of income
is as follows:
19X2
19X1
Statutory tax rate
State taxes, net of federal benefit
Effective tax rate

34%

40%

1

1

35%

41%

5. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in note 12 of Sample Hospital
and therefore are not repeated here.]
6. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample Hospital
and therefore are not repeated here.]
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Deferred financing costs (net of
accumulated amortization of $28,000
and $21,000)

Accumulated depreciation

Property and equipment
Land
Land improvements
Buildings and improvements
Furniture and equipment

Assets whose use is limited
Under note agreement—investments
By board for capital improvements—
investments

Total current assets

Current assets
Cash
Accounts receivable (net of allowance
for doubtful accounts of $4,000
and $5,000)
Supplies
Prepaid expenses

_______________ Assets_______________

Fund deficit

Deferred revenue from advance fees

Estimated obligation to provide future
services and use of facilities in excess
of amounts received or to be received
for such services

Refundable fees

Long-term debt, less current maturities

Total current liabilities

Current liabilities
Current maturities of long-term debt
Accounts payable
Accrued expenses
Deposits on unoccupied units

_____ Liabilities and Fund Deficit_____

See accompanying notes to financial statements.

90,000
$17,744,000

15,280,000

557,000
203,000
14,564,000
698,000
16,022,000
742,000

65,000
1,818,000

100,000
2,230,000

557,000
205,000
14,573,000
752,000
16,087,000
1,194,000
14,893,000

1,753,000

2,130,000

556,000

617,000

330,000

197,000
21,000
8,000

$

19X4

187,000
40,000
15,000

375,000

83,000
$17,823,000

$

19X5

December 3 1 , 19X5 and 19X4

Balance Sheets

SAMPLE CONTINUING CARE RETIREMENT COMMUNITY

(952,000)

$17,744,000

(1,489,000)

9,585,000

9,304,000

144,000

8,935,000

469,000

77,000
174,000
178,000
40,000

100,000

$

19X4

88,000

59,000

8,871,000

453,000

90,000
180,000
161,000
22,000

$17,823,000

$

19X5

SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
Statements of Revenue and Expenses and Changes in Fund Deficit
Years Ended December 31,19X5 and 19X4

Revenue
Resident fees earned including amortization of deferred revenue from
nonrefundable advance fees of $935,000 and $915,000
Patient revenue from nonresidents
Investment income
Other
Expenses
Resident care
Dietary
Health care
Plant
General and administrative
Depreciation
Interest

Decrease (increase) in obligation to provide future services and use of
facilities to current residents

Income (loss) from operations

Nonoperating gains—Contributions
Revenue and gains in excess of (less than) expenses
Fund deficit, beginning of year
Fund deficit, end of year

See accompanying notes to financial statements.

107

19X5

19X4

$ 3,946,000
249,000
107,000
75,000

$ 3,152,000
275,000
78,000
68,000

4,377,000

3,573,000

649,000
781,000
185,000
491,000
436,000
452,000
967,000

566,000
701,000
170,000
421,000
445,000
447,000
955,000

3,961,000

3,705,000

416,000

(132,000)

12,000

(82,000)

428,000

(214,000)

109,000

73,000

537,000

(141,000)

(1,489,000)

(1,348,000)

$ (952,000)

$(1,489,000)

SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
Statements of Cash Flows
Years Ended December 31,19X5 and 19X4

Cash flows from operating activities and nonoperating gains
Cash received from residents and third-party payors
Other receipts from operations
Investment income received
Contributions received
Cash paid to employees and suppliers
Interest paid

19X5

19X4

$ 3,252,000
75,000
109,000
107,000
(2,589,000)
(950,000)

$ 2,341,000
68,000
73,000
78,000
(2,042,000)
(945,000)
(427,000)

4,000

Net cash provided (used) by operating activities and nonoperating gains
Cash flows from investing activities
Acquisition of property and equipment
Cash invested in assets whose use is limited
Assets whose use is limited used for acquisition of property and equipment

(65,000)
(412,000)
—

(250,000)
(238,000)
467,000

Net cash used by investing activities

(477,000)

(21,000)

Cash flows from financing activities
Proceeds from advance fees and deposits
Refunds of advance fees and deposits
Proceeds from issuance of long-term debt
Repayments of long-term debt

615,000
(46,000)
26,000
(77,000)

857,000
(52,000)
—
(307,000)

518,000

498,000

45,000
330,000

50,000
280,000

Net cash provided by financing activities

Net increase in cash
Cash at beginning of year

Cash at end of year

330,000

$

375,000

$

$

537,000

$ (141,000)

Reconciliation of Revenue and Gains in Excess of (Less Than) Expenses
to Net Cash Provided (Used) by Operating Activities and Nonoperating Gains

Revenue and gains in excess of (less than) expenses
Adjustments to reconcile revenue and gains in excess of (less than) expenses
to net cash provided (used) by operating activities and nonoperating gains
Amortization of advance fees
Loss (gain) on obligation to provide future services
Depreciation and amortization
Provision for bad debts
Net change in other assets and liabilities [details omitted for editorial
*]
brevity
Net cash provided (used) by operating activities and
nonoperating gains

$

(935,000)
(12,000)
459,000
3,000

(915,000)
82,000
475,000
3,000

(48,000)

69,000

4,000

$ (427,000)

See accompanying notes to financial statements.

*FASB Statement 95, Statement of Cash Flows, paragraph 29 [AC C25.127], requires that "The reconciliation of net
income to net cash flow from operating activities.. .shall separately report all major classes of reconciling items".
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
Notes to Financial Statements
December 31,19X5 and 19X4

1. Summary of Significant Accounting Policies

Sample Continuing Care Retirement Community (CCRC) provides housing, health care, and other related services
to residents through the operation of a retirement facility containing 249 apartments and a seventy-eight-bed health
care facility. A summary of significant accounting policies follows.
Advance fees
Fees paid by a resident upon entering into a continuing care contract, net of the portion thereof that is refundable
to the resident, are recorded as deferred revenue and are amortized to income using the straight-line method over
the estimated remaining life expectancy of the resident.

Obligation to provide future services and use of facilities
CCRC annually calculates the present value of the net cost of future services and use of facilities to be provided to
current residents and compares that amount with the balance of deferred revenue from advance fees. If the present
value of the net cost of future services and use of facilities exceeds the deferred revenue from advance fees, a liability
is recorded (obligation to provide future services and use of facilities to current residents) with the corresponding
charge to income. The obligation is discounted at 9 percent, based on the expected long-term rate of return on
government obligations.

Investments
Investments, which consist of U.S. Treasury obligations, are stated at cost, which approximates fair market value.
Interest and investment income are recognized when earned.
2. Property and Equipment

Property and equipment are stated at cost. Donated property is recorded at its estimated fair value at date of receipt,
which then is treated as cost. Depreciation is computed on the straight-line method based on the following
estimated useful lives:
Land improvements
Buildings and improvements
Furniture and equipment

20 years
40 years
5-15 years

When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from
the accounts, and any resulting gain or loss is recognized in income for the period. The cost of maintenance and
repairs is expensed as incurred; significant renewals and betterments are capitalized.

3. Deferred Financing Costs

Deferred financing costs are being amortized using the interest method over the term of the related financing
agreement.
4. Tax Status

CCRC is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and is exempt
from federal income taxes pursuant to Section 501(a) of the Internal Revenue Code.
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5. Long-Term Debt
Long-term debt at December 31,19X5 and 19X4, is as follows:

10.75% mortgage note payable
Notes payable to bank—unsecured
Other
Less current maturities

19X5

19X4

$8,901,000
34,000
26,000

$8,965,000
14,000
33,000

8,961,000
90,000

9,012,000
77,000

$8,871,000

$8,935,000

The mortgage note is payable in consecutive monthly installments of principal and interest of $85,425 to May 20XX.
The note is collateralized by a first mortgage on property and equipment with a depreciated value at December 31,
19X5, of $14,893,000 and by a pledge of all operating revenue.

As required by the mortgage note agreement, CCRC established an initial debt service reserve fund of $1,000,000
at April 15,19X3. All resident fees received thereafter, net of resident fee refunds and debt service payments not to
exceed $300,000 annually in the first four years and $200,000 annually thereafter, are to be added to the debt service
reserve fund until the total sum of $2,050,000 is accumulated. Since June 1,19X4, CCRC is required to deliver to the
Trustee $5,500 per month to establish maintenance reserves until the aggregate of such payments equals a residen
tial unit reserve and a health care center reserve of $240,000 and $90,000, respectively. At December 31, 19X5, the
trustee held investments aggregating $2,130,000. Such amount has been classified as assets whose use is limited.

Scheduled annual principal maturities of long-term debt for the next five years are as follows:
$ 90,000
90,000
95,000
105,000
105,000

19X6
19X7
19X8
19X9
19Y0

6. Assets Whose Use Is Limited
[The disclosures contained in this note would be similar to the disclosures contained in Note 5 of Sample Hospital
and therefore are not repeated here.]

7. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in Note 12 of Sample Hospital
and therefore are not repeated here.]

8. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in Note 15 of Sample Hospital
and therefore are not repeated here.]
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Deferred finance charges, net of
accumulated amortization of
$15,000 in 19X5 and $10,000 in 19X4

Net equipment

Less accumulated depreciation

Vehicles

Equipment
Medical and office equipment

Assets whose use is limited (note 3)
Cash
Bank certificates of deposit

Total current assets

Current assets
Cash and cash equivalents
Investments
Accounts receivable, net of
estimated
uncollectibles of $61,000 in 19X5
and $30,000 in 19X4
Other receivables

______________ Assets______________

Fund balance

Long-term debt less current maturities
(note 4)

Total current liabilities

Current liabilities
Current maturities of long-term
debt (note 4)
Accounts payable
Accrued payroll and vacation costs
Estimated third-party payor
settlements (note 2)
Advances from third-party payors

Liabilities and Fund Balance

19X4

See accompanying notes to financial statements.

$853,000

25,000

39,000
37,000
76,000
24,000
52,000

135,000

135,000

56,000
50,000
106,000
45,000
61,000

35,000
100,000

476,000
22,000
641,000

752,000
27,000
965,000

35,000
100,000

$ 41,000
102,000

19X4

3 1 , 19X5 and

74,000
112,000

20,000
$1,181,000

$

19X5

December

Balance Sheets

SAMPLE HOME HEALTH AGENCY

105,000

28,000
70,000
647,000

13,000
40,000
496,000

429,000
$1,181,000

$

19X5

$853,000

252,000

118,000

483,000

31,000
66,000

$ 13,000
21,000
352,000

19X4

SAMPLE HOME HEALTH AGENCY
Statements of Revenue and Expenses and Changes in Fund Balance
Years Ended December 31,19X5 and 19X4

Net patient service revenue (note 2)

19X5

19X4

$ 4,042,000

$ 2,687,000

27,000

32,000

4,069,000

2,719,000

Other revenue
Total revenue
Expenses (note 5)
Professional care of patients
General and administrative
Occupancy
Provision for bad debts
Depreciation
Interest

2,714,000
1,042,000
90,000
46,000
21,000
16,000

1,835,000
675,000
83,000
21,000
15,000
19,000

Total expenses

3,929,000

2,648,000

140,000

71,000

19,000
18,000

15,000
12,000

Income from operations
Nonoperating gains
Contributions
Investment income
Total nonoperating gains

37,000

27,000

Revenue and gains in excess of expenses

177,000

98,000

Fund balance at beginning of year

252,000

154,000

Fund balance at end of year

$
See accompanying notes to financial statements.

112

429,000

$

252,000

SAMPLE HOME HEALTH AGENCY
Statements of Cash Flows
Years Ended December 31,19X5 and 19X4

Cash flows from operating activities and nonoperating gains
Cash received from customers and third-party payors
Other receipts from operations
Cash paid to employees and suppliers
Interest paid
Nonoperating gains

19X5

19X4

$ 3,721,000
22,000
(3,683,000)
(11,000)
37,000

$ 2,542,000
32,000
(2,540,000)
(14,000)
27,000

Net cash provided by operating activities and nonoperating gains

Cash flows from investing activities
Purchase of equipment
Purchase of investments
Net cash used by investing activities
Cash flows from financing activities
Payment of long-term debt

Net cash used by financing activities

86,000

47,000

(30,000)
(10,000)

(19,000)
(15,000)

(40,000)

(34,000)

(13,000)

—

(13,000)

—

Net increase in cash and cash equivalents

33,000

Cash and cash equivalents at beginning of year

41,000

$

Cash and cash equivalents at end of year

74,000

13,000
28,000

$

41,000

Reconciliation of Revenue and Gains in Excess of Expenses to Net Cash Provided
by Operating Activities and Nonoperating Gains
Revenue and gains in excess of expenses
Adjustments to reconcile revenue and gains in excess of expenses
to net cash provided by operating activities and nonoperating gains
Provision for bad debts
Depreciation and amortization
Increase in accounts receivable
Increase in other receivables
Increase in accounts payable and accrued expenses
Decrease (increase) in estimated third-party receivables
Increase in advances from third-party payors

$ 177,000

Net cash provided by operating activities and nonoperating gains

$ 86,000

See accompanying notes to financial statements.
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46,000
26,000
(322,000)
(5,000)
163,000
(3,000)
4,000

$ 98,000

21,000
20,000
(150,000)
(2,000)
50,000
3,000
7,000

$ 47,000

SAMPLE HOME HEALTH AGENCY

Notes to Financial Statements
Years Ended December 31,19X5 and 19X4

1. Summary of Significant Accounting Policies
Sample Home Health Agency (the Agency) was incorporated in 19X0 as a not-for-profit corporation. The Agency
provides health and supportive services to individuals at their homes.

Charity care
The Agency has a policy of providing charity care to patients who are unable to pay. Such patients are identified
based on financial information obtained from the patient and subsequ
ent analysis. Since the Agency does not expect
payment, estimated charges for charity care are not included in revenue.
Net patient service revenue
Net patient service revenue represents the estimated net realizable amounts from patients, third-party payors, and
others for services rendered.
Income taxes
The Agency is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and is
exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.

Assets whose use is limited
Assets set aside for board-designated purposes are classified as assets whose use is limited.
Investments
Investments consist of U.S. Treasury obligations at cost, which approximates market value.
Equipment
Equipment is recorded at cost. Depreciation is computed using the straight-line method over the estimated useful
lives of the assets.

Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three months
or less, excluding amounts whose use is limited by board designation.

2. Third-Party Rate Adjustments and Revenue
Approximately 38 percent in 19X5 and 37 percent in 19X4 of net patient service revenue was derived under federal
and state third-party reimbursement programs. These revenues are based, in part, on cost reimbursement prin
ciples and are subject to audit and retroactive adjustment by the respective third-party fiscal intermediaries. In the
opinion of management, retroactive adjustments, if any, would not be material to the financial position, results of
operations or cash flows of the Agency.
3. Board-Designated Assets
The board of directors has designated cash and investments aggregating $135,000 to be used for future major capital
improvements. Those assets are classified in the balance sheets as assets whose use is limited.
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4. Long-Term Debt
Long-term debt at December 31,19X5 and 19X4, is as follows:

Note payable to bank, interest at 15%, collateralized by equipment
with a depreciated cost in 19X5 of $42,000
Less current maturities
Long-term debt, less current maturities

19X5

19X4

$118,000
13,000
$105,000

$131,000
13,000
$118,000

Scheduled maturities of long-term debt at December 31,19X5 are as follows
19X6
19X7
19X8
19X9
19X0
Thereafter

$ 13,000
13,000
13,000
13,000
13,000
53,000

Total

$118,000

5. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in note 12 of Sample
Hospital.]

6. Charity Care
Charity care represented approximately 3 percent and 4 percent of visits in 19X5 and 19X4, respectively.

7. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample
Hospital.]
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Total assets

Debt issuance costs, net of accumulated
amortization of $42,000 in 19X5 and
$39,000 in 19X4

State guaranty fund deposit (note 5)

Property and equipment (notes 3 and 4)
Less accumulated depreciation and
amortization

Total current assets

balance

Total liabilities and fund

Fund balance

Commitments and contingencies
(notes 2 and 8)

Long-term debt, less portion payable
within one year (note 4)

Total current liabilities

Current liabilities
Unsecured 12% note payable to a bank
Portion of long-term debt payable
within one year (note 4)
Accounts payable—medical
services
Other accounts payable and
accrued expenses
Unearned premium revenue

______ Liabilities and Fund Balance______

19X4

See accompanying notes to financial statements.

21,000

150,000

150,000

$ 7,769,000

5,626,000

18,000

1,436,000

1,803,000
5,756,000

$ 9,869,000

7,062,000

7,559,000

193,000
828,000
407,000
261,000
184,000
99,000

1,972,000

$

19X4

3 1 , 19X5 and

3,945,000

2,000
2,935,000
358,000
263,000
190,000
197,000

Current assets
Cash
Temporary cash investments
Premiums receivable
Other receivables
Supplies
Prepaid expenses
$

19X5

_________________ Assets _________________

December

Balance Sheets

SAMPLE HEALTH MAINTENANCE ORGANIZATION

$9,869,000

2,118,000

4,295,000

829,000
141,000
3,456,000

$7,769,000

900,000

4,382,000

2,487,000

661,000
202,000

1,471,000

44,000

2,245,000

$

109,000

—

19X4

241,000

$

19X5

SAMPLE HEALTH MAINTENANCE ORGANIZATION
Statements of Revenue and Expenses
and Changes in Fund Balance
Years Ended June 30,19X5 and 19X4

Revenue
Premiums earned
Coinsurance
Interest and other income

Expenses
Contracted hospital, physician, and other services
Health centers—medical services
Health centers—administration
General administration
Membership services
Interest
Depreciation and amortization

Income from operations

Fund balance at beginning of year

19X5

19X4

$27,682,000
689,000
242,000

$22,500,000
500,000
100,000

28,613,000

23,100,000

12,749,000
10,116,000
1,556,000
1,695,000
527,000
385,000
367,000

9,734,000
8,786,000
1,530,000
1,309,000
440,000
375,000
336,000

27,395,000

22,510,000

1,218,000

590,000

900,000

310,000

$ 2,118,000

Fund balance at end of year

See accompanying notes to financial statements.
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$

900,000

SAMPLE HEALTH MAINTENANCE ORGANIZATION

Statements of Cash Flows
Years Ended June 30,19X5 and 19X4

Cash flows from operating activities
Cash received from premiums, stop-loss insurance recoveries,
and coinsurance
Cash paid to employees and to providers of health care services
Interest received
Interest paid

19X5

19X4

$ 28,969,000
(26,405,000)
230,000
(382,000)

$ 24,410,000
(22,818,000)
90,000
(372,000)
1,310,000

2,412,000

Net cash provided by operating activities

Cash flows from investing activities
Additions to property and equipment
Net cash used by investing activities
Cash flows from financing activities
Proceeds from long-term debt
Repayment of long-term debt

Net cash provided (used) by financing activities

(497,000)

(121,000)

(497,000)

(121,000)

300,000
(299,000)

(1,000,000)
(1,000,000)

1,000

Net increase in cash and temporary cash investments

1,916,000

189,000

Beginning cash and temporary cash investments

1,021,000

832,000

$ 2,937,000

$ 1,021,000

$ 1,218,000

$

Ending cash and temporary cash investments
Reconciliation of Income From Operations to Net Cash Provided
by Operating Activities
Income from operations

Adjustments to reconcile income from operations to net cash provided
by operating activities
Depreciation and amortization
Increase in accounts payable—medical services
Increase (decrease) in unearned premium revenue
Decrease in premiums receivable
Net effect of changes in other receivables, supplies, prepaid expenses,
and other payables

370,000
774,000
(61,000)
49,000

339,000
335,000
115,000
84,000

62,000

(153,000)

$ 2,412,000

Net cash provided by operating activities

See accompanying notes to financial statements.
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590,000

$ 1,310,000

SAMPLE HEALTH MAINTENANCE ORGANIZATION
Notes to Financial Statements
June 30,19X5 and 19X4

1. Formation and Purpose
Sample Health Maintenance Organization (Sample HMO) was incorporated in 19X0 as a not-for-profit corporation
for the purpose of providing comprehensive health care services on a prepaid basis and for the purpose of establish
ing and operating organized health maintenance and health care delivery systems.
Sample HMO has been determined to be a qualified health maintenance organization (HMO) under Title XIII of the
Public Health Service Act.

2. Summary of Significant Accounting Policies
Temporary cash investments
Temporary cash investments at June 30,19X5 and 19X4, include a repurchase agreement with a bank and certificates
of deposit with original maturities of less than ninety days carried at a cost that is equivalent to market.

Premiums revenue
Membership contracts are on a yearly basis subject to cancellation by the employer group or Sample HMO upon
thirty days written notice. Premiums are due monthly and are recognized as revenue during the period in which
Sample HMO is obligated to provide services to members.

Health care service cost recognition
Sample HMO contracts with various health care providers for the provision of certain medical care services to its
members. Sample HMO compensates those providers on a capitation basis. As part of a cost control incentive
program, Sample HMO retains up to XX percent of the capitation as a risk-sharing fund. In the event of hospital
utilization in excess of budget, those providers bear the risk to the extent of XX percent of the capitation fee.
Operating expenses include all amounts incurred by Sample HMO under the aforementioned contracts.
The cost of other health care services provided or contracted for is accrued in the period in which it is provided
to a member based in part on estimates, including an accrual for medical services provided but not reported to
Sample HMO.

Inventories of supplies
Inventories of drugs and other supplies are stated at the lower of cost (first-in, first-out) or market.

Property and equipment
Property and equipment are recorded at cost, less accumulated depreciation. Maintenance and repairs are charged
to expense, and betterments are capitalized. Property and equipment costing approximately $700,000 was financed
by initial development grants received in 19X1 and 19X2 from the U.S. Department of Health and Human Services.
This property will be owned by Sample HMO as long as the equipment and facilities are used for projects related
to the objectives of the Public Health Service Act.
Depreciation is computed using the straight-line method over the estimated useful lives of the related assets as
follows:
Building
Improvements
Data processing and laboratory equipment and automobiles
Medical equipment
Office equipment

40years
20-25years
3-7years
10years
5-10years

Amortization of debt issuance costs
Debt issuance costs are deferred and amortized using the interest method over the term of the related debt.
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Retirement plan expense
Sample HMO has a retirement plan as more fully described in note 6. Charges to expense are recognized when
Sample HMO makes contributions to the plan.
Federal income tax
Sample HMO is exempt from federal income taxes under Section 501(c)(4) of the Internal Revenue Code; accord
ingly, no provision for federal income taxes has been made in the accompanying financial statements.

Reinsurance (stop-loss insurance)
Reinsurance premiums are reported as health care costs, and reinsurance recoveries are reported as revenue.

3. Property and Equipment
Property and equipment at June 30,19X5 and 19X4, consists of the following:

19X4

19X5

$

Land
Buildings and improvements
Furniture and equipment
Less accumulated depreciation

300,000
5,473,000
1,786,000

$

300,000
5,459,000
1,303,000

7,559,000

7,062,000

1,803,000

1,436,000

$ 5,756,000

$ 5,626,000

4. Long-Term Debt
Long-term debt is collateralized by assets with a depreciated cost at June 30,19X5 of $4,943,000. A summary of long
term debt at June 30, 19X5 and 19X4, follows.

HHS loan, interest at 7.5%
HHS loan, interest at 9.25%
Secured equipment loans
Less portion payable within one year

19X5

19X4

$ 2,020,000
1,658,000
858,000

$ 2,111,000
1,694,000
686,000

4,536,000

4,491,000

241,000

109,000

$ 4,295,000

$ 4,382,000

Scheduled principal payments on long-term debt are as follows:
Fiscal Year

Scheduled Principal
Payments

19X6
19X7
19X8
19X9
19Y0

$ 241,000
259,000
280,000
800,000
2,956,000

$4,536,000
5. State Guarantee Fund Deposit

In August 19X5 the state in which Sample HMO is domiciled enacted legislation specifically governing HMOs.
Under this legislation, Sample HMO is required to maintain a deposit of $150,000 with the director of the division
of insurance of the state.
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6. Employee Retirement Plan

Sample HMO has a contributory defined contribution retirement plan covering substantially all employees.
Expense determined in accordance with the plan formula (4 percent to 10 percent of eligible covered compensation)
was $354,000 for the year ended June 30,19X5 ($275,000 for 19X4).
7. Stop-loss Insurance

Sample HMO has entered into a stop-loss insurance agreement with an insurance company to limit its losses
on individual claims. Under the terms of this agreement, the insurance company will reimburse Sample HMO
approximately XX percent of the cost of each member's annual hospital services, in excess of a $XXX deductible,
up to a lifetime limitation of $XXX per member. In the event Sample HMO ceases operations, (a) plan benefits will
continue for members who are confined in an acute care hospital on the date of insolvency until their discharge and
(b) plan benefits will continue for any other member until the end of the contract period for which premiums have
been paid.

Stop-loss insurance premiums of approximately $700,000 and $500,000 are included in health care costs in 19X5 and
19X4, respectively. Approximately $600,000 and $400,000 of stop-loss insurance recoveries are deducted from health
care costs in 19X5 and 19X4, respectively.

Included in other receivables is approximately $50,000 recoverable from insurers.
8. Malpractice Claims

Malpractice claims have been asserted against Sample HMO by various claimants. The claims are in various stages
of processing, and some may ultimately be brought to trial. In the opinion of counsel, the outcome of these actions
will not have a significant effect on the financial position, results of operations or cash flows of Sample HMO.
Incidents occurring through June 30, 19X5, may result in the assertion of additional claims. Other claims may be
asserted arising from past services provided. Management believes that these claims, if asserted, would be settled
within the limits of insurance coverage.

9. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample Hospital.]
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Total assets

Advances receivable (note 5)

Less accumulated depreciation
Net property and equipment

Property and equipment, at cost
Land
Land improvements
Buildings
Equipment

Total current assets

Current assets
Cash
Patient accounts receivable less allowance
for uncollectible accounts
19X5—$15,000; 19X4-$5,000
Estimated retroactive adjustments—
third-party payors (note 4)
Accounts receivable—other
Supplies
Prepaid expenses and deposits

_________________ Assets_________________

5,000
$2,819,000

14,000
$2,704,000

Total liabilities and fund balance

Fund balance

Commitment (note 5)

Total current liabilities

Current liabilities
Notes payable (note 3)
Accounts payable
Accrued payroll, benefits, and taxes
Estimated retroactive adjustments—
third-party payors (note 4)
Financing advance from third-party payor

______ Liabilities and Fund Balances______

19X4

See accompanying notes to financial statements.

100,000
2,393,000

100,000
322,000
682,000
1,389,000
2,493,000

421,000

413,000
100,000
322,000
682,000
1,390,000
2,494,000

32,000
8,000
18,000
9,000

19,000
13,000
21,000
5,000

76,000

278,000

$

290,000

65,000

19X4

3 1 , 19X5 and

217,000
2,277,000

$

19X5

December

Balance Sheets

SAMPLE AMBULATORY CARE, INC.

—

2,451,000
$2,704,000

2,541,000
$2,819,000

—

278,000

253,000

—

24,000
1,000

$ 144,000
87,000
22,000

19X4

30,000

$ 138,000
52,000
33,000

19X5

SAMPLE AMBULATORY CARE, INC.
Statements of Revenue and Expenses
and Changes in Fund Balance
Years Ended December 31,19X5 and 19X4

19X5

19X4

$ 860,000

$ 357,000

26,000

14,000

886,000

371,000

425,000
77,000
107,000
177,000
34,000
27,000
15,000
117,000

184,000
54,000
52,000
109,000
22,000
1,000
17,000
100,000

Total expenses

979,000

539,000

Loss from operations

(93,000)

(168,000)

Nonoperating gain—interest income

3,000

11,000

(90,000)

(157,000)

Net patient service revenue (note 7)
Operating gains
Total operating revenue and gains

Expenses
Salaries and wages
Employee benefits
Supplies
Purchased services
Insurance
Professional fees
Interest
Depreciation

Expenses in excess of revenue and gains
Fund balance at beginning of period

Fund balance at end of period
See accompanying notes to financial statements.
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2,541,000

2,698,000

$2,451,000

$2,541,000

SAMPLE AMBULATORY CARE, INC.
Statements of Cash Flows
Years Ended December 31,19X5 and 19X4

Cash flows from operating activities and gains
Cash received from patients and third-party payors
Cash received from others
Interest received
Interest paid
Cash paid to employees and suppliers

19X5

19X4

$ 866,000
21,000
3,000
(15,000)
(870,000)

$ 368,000
6,000
11,000
(16,000)
(432,000)

Net cash provided from (used for) operating activities and gains

Cash flows from investing activities
Purchase of equipment
Advances made
Net cash used for investing activities

Cash flows from financing activities
Proceeds from notes payable
Payments on notes payable

(63,000)

(1,000)
(9,000)

(4,000)
(5,000)

(10,000)

(9,000)

—
(6,000)

144,000
—

(6,000)

144,000

(11,000)

72,000

76,000

4,000

$ 65,000

$ 76,000

$ (90,000)

$(157,000)

117,000
14,000
(12,000)
1,000

100,000
4,000
(19,000)
(2,000)

(25,000)

11,000

Net cash provided from (used for) financing activities
Net increase (decrease) in cash
Cash at beginning of year

Cash at end of year

5,000

Reconciliation of Expenses in Excess of Revenues and Gains to Net Cash Provided
From (Used For) Operating Activities and Gains
Net loss
Adjustments to reconcile expenses in excess of revenues and gains to
net cash provided from (used for) operating activities and gains
Depreciation
Provision for bad debts
Net increase in receivables and net third-party payor adjustments
Net decrease (increase) in inventories of supplies, prepaid expenses and deposits
Net increase (decrease) in accounts payable, accrued expenses and advances
from Blue Cross
Net cash provided from (used for) operating activities and gains

See accompanying notes to financial statements.
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$

5,000

$ (63,000)

SAMPLE AMBULATORY CARE, INC.
Notes to Financial Statements
December 31,19X5 and 19X4

1. Summary of Significant Accounting Policies

Net patient service revenue
Patient service revenue is reported at the estimated net realizable amounts from patients, third-party payors, and
others for services rendered.
Third-party contractual adjustments
Retroactively calculated third-party contractual adjustments are accrued on an estimated basis in the period the
related services are rendered. Net patient service revenue is adjusted as required in subsequent periods based on
final settlements.
Charity care
Sample Ambulatory Care, Inc. has a policy of providing charity care to patients who are unable to pay. Such patients
are identified and related charges are estimated, based on financial information obtained from the patient and
subsequent analysis. Since management does not expect payment for charity care, the estimated charges are
excluded from revenue.

Supplies
Supplies are stated at the lower of cost (first-in, first-out) or net realizable value.
Depreciation
Depreciation of property and equipment is computed on the straight-line method over the estimated lives of
depreciable assets.

Investment income
Investment income and gains on investment transactions are recorded as nonoperating revenue.
2. Formation and Scope of Operations

Sample Ambulatory Care, Inc. was incorporated on September 7,19X3, to operate an ambulatory care health facility
to treat or prevent injury and disease, to provide funds or to expend funds to further the treatment or prevention
of injury or disease, and to develop and participate in activities designed to promote the general health of the
community.
Three area hospitals—ABC Hospital and Health Center, DEF Hospital, and GHI Hospital—entered into a members'
agreement to develop this ambulatory care center. In accordance with this agreement, each hospital contributed
capital of $947,000 to Sample Ambulatory Care, Inc.

Sample Ambulatory Care, Inc. began operations in October 19X3.
3. Related Party Transactions

During 19X3, Sample Ambulatory Care, Inc. entered into a contract with one of the member hospitals (managing
hospital) for the management of the business and affairs of Sample Ambulatory Care, Inc. Under this agreement,
Sample Ambulatory Care, Inc. pays $4,000 per month to the managing hospital. The agreement with the managing
hospital was to remain in effect through December 31,19X5, but has been extended on a month-to-month basis.

In addition, during 19X4, each hospital loaned $48,000 to Sample Ambulatory Care, Inc. in the form of promissory
notes at an interest rate of prime plus one percent (effective rates of 10 percent and 9 percent in 19X5 and 19X4,
respectively). Of the total $144,000 liability, $48,000 is payable on demand after November 28,19X5, to one member
hospital, with the remaining portion ($96,000) payable on demand after December 8,19X5, to the other two member
hospitals. During 19X5, Sample Ambulatory Care, Inc. paid $2,000 to each member hospital, thereby reducing the
obligation to $138,000.
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4. Revenue From Contracting Agencies

Sample Ambulatory Care, Inc. participates as a provider of health care services to Blue Cross, Medicare, and
County Indigent Plan patients. Reimbursement for covered services is based on tentative payment rates. Final
reimbursement rates are determined after submission of annual cost reports and audits thereof by the fiscal inter
mediaries. Provisions for estimated reimbursement adjustments are reported in the financial statements in the
period that the services are rendered.
5. Advances Receivable

In May 19X4 Sample Ambulatory Care, Inc. entered into a five-year agreement with XYZ Affiliates (XYZ). Under
this agreement, XYZ is to provide emergency medical services as well as charge and bill each patient treated at
Sample Ambulatory Care, Inc. Sample Ambulatory Care, Inc. has guaranteed that XYZ will collect at least $18,000
per month during the term of this agreement. In any month in which XYZ does not collect the minimum guarantee,
Sample Ambulatory Care, Inc. advances funds to XYZ to cover the deficiency. Such advances are to be repaid to the
extent XYZ's net cash collections exceed the minimum guarantee amount. Management estimates that the advances
will be fully recovered in 19X6.
6. Income Taxes

Sample Ambulatory Care, Inc. is a not-for-profit corporation as described in Section 501(c)(3) of the Internal
Revenue Code and is exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.
7. Charity Care

Sample Ambulatory Care, Inc. has a policy of providing charity care to indigent patients in emergency situations.
These services, which are excluded from revenues, amounted to $27,000 and $13,000 in 19X3 and 19X4, respectively,
when measured at Sample Ambulatory Care, Inc.'s established rates.
8. Concentrations of Credit Risk

[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample Hospital.]
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UNQUALIFIED OPINION—COMPARATIVE
FINANCIAL STATEMENTS
Independent Auditor's Report

[Date]

To the Board of Trustees
XYZ Health Care Entity
We have audited the accompanying balance sheets of XYZ Health Care Entity as of September 30,19X2 and 19X1,
and the related statements of revenue and expenses of general funds, changes in fund balances, and cash flows of
general funds for the years then ended. These financial statements are the responsibility of XYZ Health Care
Entity's management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing standards. Those standards require that
we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also includes assessing the accounting principles used and signifi
cant estimates made by management, as well as evaluating the overall financial statement presentation. We believe
that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial posi
tion of XYZ Health Care Entity as of September 30,19X2 and 19X1, and the results of its operations and its cash flows
of general funds for the years then ended in conformity with generally accepted accounting principles.

[Signature]
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UNQUALIFIED OPINION WITH EXPLANATORY PARAGRAPH —
MATERIAL UNCERTAINTY
Independent Auditor's Report

[Date]

To the Board of Trustees
XYZ Health Care Entity
[Standard wording for first three paragraphs]

As more fully described in note X, claims in excess of professional liability insurance coverage have been asserted
against XYZ Health Care Entity. Legal counsel and management are unable to estimate the ultimate cost, if any, that
may result from the resolution of those claims; accordingly, no provision for claims in excess of professional liability
insurance has been made in the accompanying financial statements.

[Signature]
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QUALIFIED OPINION—SCOPE LIMITATION
Independent Auditor's Report

[Date]

To the Board of Trustees
XYZ Health Care Entity

[Same first paragraph as the standard report]

Except as discussed in the following paragraph, we conducted our audits in accordance with generally accepted
auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance
about whether the financial statements are free of material misstatement. An audit includes examining, on a test
basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by management, as well as evaluating the
overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
We were unable to obtain audited financial statements supporting XYZ Health Care Entity's investment in an
affiliate stated at $____________ and $_____________at September 30,19X2 and 19X1, respectively, or its equity in the
earnings of that affiliate of $____________ and $_____________ , which amounts are included in the excess of
revenues and gains over expenses for the years then ended as described in Note X to the financial statements; nor
were we able to satisfy ourselves as to the carrying value of the investment in the affiliate or the equity in its earnings
by other auditing procedures.

In our opinion, except for the effects of such adjustments, if any, as might have been determined to be necessary
had we been able to obtain adequate evidence regarding the affiliate investment and earnings, the financial statements
referred to in the first paragraph present fairly, in all material respects, the financial position of XYZ Health Care
Entity as of September 30,19X2 and 19X1, and the results of its operations and its cash flows of general funds for
the years then ended in conformity with generally accepted accounting principles.

[Signature]
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STANDARD REVIEW REPORT ON FINANCIAL
STATEMENTS—NONPUBLIC ENTITY

[Date]

To the Board of Trustees
XYZ Health Care Entity
We have reviewed the accompanying balance sheet of XYZ Health Care Entity as of December 31,19XX, and the
related statements of revenue and expenses of general funds, changes in fund balances, and cash flows of general
funds for the year then ended, in accordance with Statements on Standards for Accounting and Review Services
issued by the American Institute of Certified Public Accountants. All information included in these financial state
ments is the representation of the management of XYZ Health Care Entity.
A review consists principally of inquiries of entity personnel and analytical procedures applied to financial data. It
is substantially less in scope than an audit in accordance with generally accepted auditing standards, the objective
of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do
not express such an opinion.
Based on our review, we are not aware of any material modifications that should be made to the accompanying
financial statements in order for them to be in conformity with generally accepted accounting principles.

[Signature]
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STANDARD COMPILATION REPORT ON FINANCIAL
STATEMENTS—NONPUBLIC ENTITY

[Date]

To the Board of Trustees
XYZ Health Care Entity
We have compiled the accompanying balance sheet of XYZ Health Care Entity as of December 31,19XX, and the
related statements of revenue and expenses of general funds, changes in fund balances, and cash flows of general
funds for the year then ended, in accordance with Statements on Standards for Accounting and Review Services
issued by the American Institute of Certified Public Accountants.

A compilation is limited to presenting in the form of financial statements information that is the representation of
management. We have not audited or reviewed the accompanying financial statements and, accordingly, do not
express an opinion or any other form of assurance on them.

[Signature]
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TECHNICAL HOTLINE
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inquiries about specific audit or accounting problems.

Call Toll Free

(800) TO-AICPA

This service is free to AICPA members.
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